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GENERAL INTRODUCTION 
The first observations leading to the discovery of hexokinase (ATP: 
D-hexose-6-phosphotransferase, E.G. 2.7.1.1.) were made by Otto Meyerhof 
(1927, 1932). He found that the normally slow production of lactic acid 
from hexose in rabbit muscle could be accelerated by the addition of a 
protein fraction from a yeast autolysate. He called this protein hexo­
kinase because it initiated the oxidation of hexoses. In later studies, 
Meyerhof found that ATP was necessary for activity and he suggested the 
reaction, 
Me"'"^  2 Hexose + ATP  ^2 Hexose 6-phosphate + AMP, (1) 
was responsible for hexose phosphorylization. However, Colowick and 
Kalcker (1941, 1943) found that only the terminal phosphate of ATP was 
transferred in the hexokinase reaction and they suggested that Meyerhof*s 
muscle preparation probably contained myokinase activity that would 
transfer a phosphoryl group from one ADP to another forming ATP and AMP. 
This pair of reactions would yield the stoichiometry suggested by Meyer­
hof. Hexokinase alone catalyzes the following reaction: 
2- 2- 1- + 
MgATP + D-Hexose "*• D-Hexose 6-phosphate + MgADP + H (2) 
Hexokinase has been found in yeast (McDonald, 1955); bacteria 
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(Crane, 1962); locust muscle (Kerly and Leaback, 1957a); intestine, 
kidney, and heart (Cori, 1945); brain (Sols and Crane, 1954; Crane and 
Sols, 1954; Kerly and Leaback, 1957b; Schwartz and Basford, 1967); 
liver and skeletal muscle (Crane and Sols, 1955); and other tissues 
(Long, 1952; Hoare and Kerly, 1954). Enzymes of this type appear to be 
ubiquitous in nature and probably all cells capable of metabolizing 
hexoses contain at least one such enzyme (Crane, 1962). The enzymes 
show little specificity for hexose substrate(s), catalyzing the phospho­
rylation of glucose, fructose, mannose, and 2-deoxyglucose, but show 
little activity with nucleotides other than ATP. 
Of the hexokinases isolated, the yeast and mammalian isozymes are 
the most extensively studied, the yeast enzyme with regard to its kinetic 
and physical properties, and the mammalian enzymes largely with respect 
to their regulatory properties. Three isozymes of hexokinase have been 
isolated from yeast cells and designated A, B, and C. A is composed of 
identical alpha subunits while B and C are composed of beta subunits 
(Rustum et al., 1971). Isozymes B and C are conformationally rather than 
structurally different and C is converted into isozyme B under conditions 
of high ionic strength (Ramel et , 1971). The molecular weight of 
the dimer of each isozyme is approximately 100,000. 
The kinetic mechanism of yeast hexokinase has been rigorously 
investigated, in part due to the new kinetic techniques developed in 
this time period. Initially, the yeast enzyme was reported to form an 
enzyme-phosphoryl intermediate (Agren and Engstrom, 1956) or an enzyme-
3 
glucosyl intermediate (Gamble and Najjar, 1954; Najjar and McCoy, 1958). 
These results suggested that the hexokinase reaction proceeded via a 
ping-pong mechanism. However, Trayser and Colowick (1961) concluded 
that neither enzyme intermediate was formed since, by their observations, 
only negligible amounts of carbohydrate and phosphorus were associated 
with the enzyme. The mechanism of yeast hexokinase was subsequently 
demonstrated to be of the random type by the techniques of 
substrate analog competitive inhibition (Fromm and Zewe, 1962b; Zewe ^  
al., 1964), product inhibition (Fromm and Zewe, 1962b; Zewe et al., 1964; 
Fromm, 1969), isotope exchange (Fromm ^  , 1964), and alternate 
substrates and products (Fromm and Zewe, 1962b; Fromm, 1964). A more 
complete development of the kinetic studies of yeast hexokinase is 
found in the recent review by Purich et al. (1973). 
Few studies have been carried out on the mode of yeast hexokinase 
regulation. Unlike mammalian hexokinases, the yeast isozyme has a high 
dissociation constant for glucose 6-phosphate (Hammes and Kochavi, 1962) 
and does not have a great affinity for ADP. Kosow and Rose (1971) have 
suggested that P^ , citrate, malate, 3-P-glycerate, and ribonucleoside 
5'-triphosphates can function as hexokinase activators below pH 7.0. 
The activation is held to be the result of the existence of two confor­
mational states of the enzyme and accounts for both the negative coop-
erativity and the burst phenomena seen with the enzyme at neutral pH 
(Shill and Neet, 1971; Shill and Neet, 1974; Peters and Neet, 1977). 
These conclusions are questionable, however, in light of a recent report 
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by Womack and Colowick (1979). These authors show that the apparent 
negative-cooperativity and burst seen in the hexokinase reaction at pH 
7.0 are caused by the presence of aluminum ions in commercial prepara­
tions of ATP. Citrate and other ions which activate the enzyme act by 
complexation of the aluminum. 
It was not recognized until 1964 that mammalian hexokinase activity 
exists as multiple electrophoretically distinct species. Gonzalez et al. 
(1964) reported that hexokinase isozymes were present in rat liver and 
shortly thereafter Katzen et al. (1965) also obtained evidence for the 
presence of isozymic forms in human cell cultures and rat liver. In 
1965, Katzen and Schimke (1965) were able to isolate four isozymes of 
hexokinase from different mammalian tissues. The isozymes were desig­
nated type I, II, III, and IV in order of their increasing mobility on 
starch gel electrophoresis. Types I and II are both low K types (K 
m m 
-5 -4 
with respect to glucose is 10 M and 10 M for type I and II, respec-
-6  
tively). Type III also has a low K_ for glucose (~10 M) but exhibits 
substrate inhibition at higher concentrations of this hexose. These 
three isozymes represent the bulk of hexokinase found in mammalian cells. 
Each appears to be a monomer with a molecular weight of about 96,000 to 
99,000 daltons as determined by ultracentrifugation (Grossbard and 
Schimke» 1966). Grossbard and Schimke (1966) also found that the three 
isozymes had different thermal and proteolytic susceptibilities. Type 
I is most stable both to thermal and proteolytic attack while type II 
is most susceptible. All three hexokinase types are stabilized from 
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tryptic inactivation by saturating levels of glucose, but the proteolytic 
treatment leads to new, electrophoretically distinct forms. Immunolog­
ically, hexokinase I appears distinct from both hexokinase II (anti-
hexokinase II does not inhibit the enzymatic activity of hexokinase I 
(Creighton et al., 1972)) and hexokinase.Ill (the two isozymes show 
complete absence of immunological crossreactivity (Neumann et al., 1974; 
Neumann and Pfleiderer, 1974)). Neumann and Pfleiderer (1974) have 
suggested that their immunological data indicate that the low hexo-
kinases and glucokinase from mammalian tissues are all products of 
different genes and in this sense are true isozymes. Hexokinase type 
IV, called glucokinase, is a low glucose affinity isozyme (K for glucose 
-2 
~10 M) found only in the liver. Glucokinase is a monomer as are the 
other three isozymes, but has a molecular weight of only 47,000 and it can 
be cleanly separated from types I-III on Sephadex G-lOO columns (Pilkis, 
1972). Glucokinase from rat liver is reported to have no immunological 
o o — T . T n  1  o T . v  V  V » â ' v r > V * Î T n o Q o c  a T i / 4  " î  c  ï s  r > ^ r > ^ o * î r >  
m 
(Pilkis ^  , 1968) . 
The four isozymes of hexokinase found in mammalian tissue have 
assumed trivial names based upon their tissue locations. Isozyme I is 
referred to as brain hexokinase because of its abundance in this tissue 
and because of the low levels of the other isozymes in the brain. Hexo­
kinase I is found in almost all body tissue and is present in high con­
centration in erythrocytes, kidney, liver, and most organs (Katzen, 1967). 
The type II isozyme, found plentifully in muscle, fat pads, and several 
6 
organs, is referred to as muscle hexokinase, while isozyme IV, found 
predominantly in the liver is usually called glucokinase (Katzen, 1967). 
The type III isozyme is found in several tissues (liver, spleen, adrenal, 
intestines, and kidneys) but not in particularly high activity. The 
work reported in this dissertation was performed with hexokinase I, brain 
hexokinase, and unless stated otherwise the information presented here 
deals with this isozyme. 
Recently, there has been some question as to whether or not hexo­
kinase I, as identified from electrophoretic patterns, from various 
tissues represents a single isozyme. The suggestion has been made that 
tissues thought to contain hexokinase I exclusively may not also have 
other isozymes present. In brain tissue, hexokinase activity is found 
partitioned between the mitochondria and the cytosol in a ratio of 
approximately 4 to 1 (Crane and Sols, 1953; Johnson, 1960; Bachelard, 
1967). Kellogg al. (1974) showed that this ratio was not fixed, but 
varied 2 to 3 fold in developing rat brains. The authors, feeling that 
this ratio would be constant if it were caused by a partitioning of a 
single enzyme, suggested that distinct cytoplasmic and mitochondrial forms 
of hexokinase were present in the brain. However, the discovery of a 
protein which binds hexokinase I to the mitochondria (Feigner e^  , 
1979) adds a third variable which can change during development so that 
the partitioning cannot be thought of as a simple bound-soluble equili­
brium. A comparison of the kinetic parameters of cytosolic and mitochon­
drial brain hexokinase showed that the cytosolic enzyir.e had significantly 
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higher dissociation constants for the inhibitors N-acetylglucosamine 
and AMP, perhaps suggesting different isozymes or post-translational 
modifications of the brain isozyme (Thompson and Bachelard, 1977). 
Erythrocytes, thought to contain exclusively hexokinase I, have 
also been shown to contain hexokinase I subtypes. In the case of 
erythrocytes, 4 subtypes, designated la, lb, Ic, and Id, were isolated 
from human red blood cells (Rijksen ^  al., 1981). The subtypes are 
named on the basis of their electrophoretic mobilities and all migrate 
faster than hexokinase II, the muscle isozyme. Kinetically, the subtypes 
are similar in their K 's for glucose and ATP and all show marked inhi-
m 
bition by glucose-6-P. All of these parameters are consistent with 
those of hexokinase I, but the enzymes show variability in the ability 
of phosphate to reverse sugar-phosphate inhibition, the third marked 
feature of brain hexokinase activity. The lb subtype has great phos­
phate sensitivity, the Ic and Id types intermediate sensitivity and the 
la subtype is relatively insensitive to P^  modulation of glucose-6-P inhi­
bition. When the erythrocytes were fractionated according to age and the 
distribution of isozymes reexamined, Rijksen et al. (1981) found that 
hexokinase lb predominated in young cells. As the cells aged, the con­
centration of subtypes Ic, Id, and la increased as the concentration of 
hexokinase lb decreased. Since mature erythrocytes have no protein 
synthesis, and because the total activity in the cells did not increase, 
the appearance of the additional subtypes must be due to post-trans-
lational modification of the primary enzyme, probably hexokinase I. 
8 
Vowles and Easterby (1979) separated two isozymes of hexokinase I 
from pig heart, one that would bind mitochondria and a second that would 
not, while Feigner and Wilson (1976) have shown the same phenomena in 
rat brain. Additional studies on reticulocytes (Stocchi et al., 1981) 
and erythrocytes (Gahr, 1980) have shown two types of hexokinase present, 
again one type phosphate sensitive and the second showing less modulation 
by phosphate. In each study, no attempt had been made to determine 
whether ot not the subtypes displayed structural heterogeneity, but at 
this time the isozymes appear to be post-translational modifications of 
brain hexokinase. 
While these studies have all dealt with multiple subtypes of hexo­
kinase I in the same tissue, a recent report by Kurokawa et al. (1979) 
has Indicated the possibility of tissue dependent variation in hexokinase 
I isozymes. The authors found that isolated mitochondria from rat liver 
was devoid of bound hexokinase I. To test whether this phenomenon was 
due to differences in the enzyme or in the mitochondria, Kurokawa ^  al. 
conducted a series of experiments comparing the properties of hexokinase 
I and of mitochondria from brain and liver. They found that hexokinase 
I from liver did not bind to mitochondria isolated from either liver or 
brain, while hexokinase I solubilized from rat brain mitochondria would 
bind to either brain or liver mitochondrial membranes. Although this 
report is not conclusive and the characteristics of the enzymes were not 
compared, the data may indicate separate types of hexokinase I are 
present in the two tissues. 
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Because of its function in the control of energy metabolism, hexo-
kinase I is the most extensively studied of the mammalian isozymes. The 
brain, virtually totally dependent upon blood-borne glucose to supply 
its energy requirements, uses approximately 25% of the glucose and 20% 
of the oxygen consumed by the body, although it represents only 2-3% of 
the adult body weight (Bachelard, 1970; Balazs, 1970; Sokoloff, 1977). 
Erythrocytes, lacking mitochondria, depend primarily on anaerobic gly­
colysis to supply their energy needs. In both these tissues, the slow 
utilization of glucose-6-phosphate by the hexose monophosphate shunt 
(Bachelard and Mcllwain, 1969; Winick, 1970) or in glycogen storage 
(Bachelard and Mcllwain, 1969; Mcllwain, 1966) make the hexokinase 
reaction the de facto first committed step of glycolysis. The regulation 
of hexokinase I controls glycolysis in both brain and erythrocytes 
(Lowry .e^  al, 1964; Lowry and Passonneau, 1964; Rapoport, 1968). Brain 
hexokinase's importance in regulation has led to its extensive investi­
gation by many authors. 
Various kinetic mechanisms have been proposed for the brain 
enzyme during the course of its study. Early initial rate studies 
performed on the particulate bovine brain enzyme (?romm and Zewe, 
19&2a) and on the solubilized brain isozyme from rat muscle 
(Hanson and Froiûm, 1955) and from bovine brain (Copley and Fromm, 
1967) yielded Lineweaver-Burk (1934) type profiles which were consistent 
with a ping-pong mechanism and the authors suggested that this was 
tentative evidence for the formation of a phosphoryl-enzyme or glucosyl-
enzyme intermediate. These data were at variance with those for both 
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the muscle isozyme (Grossbard and Schimke, 1966; Hanson and Fromm, 1967) 
and yeast hexokinase (Hanmes and Kochavi, 1962; Fromm and Zewe, 1962b), 
each of which showed initial rate kinetics consistent only with a sequen­
tial mechanism. This discrepancy was resolved when Fromm and Ning 
(1968) reexamined the initial rate of the enzyme using D-fructose in 
place of D-glucose as the sugar substrate. When this substrate was 
used, the Lineweaver-Burk profiles displayed convergent patterns of 
lines, indicative of a sequential mechanism. The rate equation for a 
two substrate sequential mechanism is of the form: 
+ + (3) 
V " (A) + (B) * (A) (B) 
The ping-pong mechanism has a similar equation but does not contain 
the final term, j^ ia^  Apparently, when glucose is used as the sugar 
\(A)(B)/ 
substrate in the brain hexokinase reaction the last term of the rate 
equation is negligible compared to the others and the kinetic mechanism 
appears ping-pong. These results have since been obtained with the 
solubilized rat brain enzyme (Purich and Fromm, 1971), but recent studies 
on human erythrocyte hexokinase (Gerber ^  , 1974) and on hexokinase 
I from pig brain (Shone and Fromm, 1980) and from pig heart (Vowles and 
Easterby, 1979) have shown convergent patterns consistent with a sequen­
tial mechanism in their initial rate profiles. Presently there is 
agreement in the literature that the hexokinases operate with a sequen­
tial mechanism. 
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Further elucidation of the kinetic mechanism of brain hexokinase 
was attempted through the use of product inhibition studies. The first 
report of the effect of product on the hexokinase reaction was in 1951 
when Weil-Malherbe and Bone (1951) reported that glucose-6-P strongly 
inhibited a crude preparation of rat brain hexokinase in a noncompetitive 
manner with respect to both glucose and ATP. The authors concluded that 
glucose-6-P combined with the enzyme at a site different from those 
which react with either hexose or ATP. Soon after, Crane and Sols (1954), 
using a purified particulate enzyme, confirmed Weil-Malherbe's and Bone's 
earlier results in that they showed glucose-6-P was a noncompetitive 
inhibitor with respect to glucose. In addition, they cataloged the 
effects of a number of other sugar phosphates. Crane and Sols (1954) 
took their results to indicate that glucose-6-P occupied a separate 
regulatory site on the enzyme surface remote from the active site. In 
1962, Fromm and Zewe (1962a) found that although glucose-6-P was a non­
competitive inhibitor of brain hexokinase with respect to glucose, the 
sugar-phosphate inhibited the enzyme in a competitive manner with respect 
to MgATP. The authors suggested that these results were consistent with 
glucose-6-P binding to the enzyme primarily at the y-phosphate subsite 
within the ATP locus on the enzyme, and that it was not necessary to 
postulate a second site. The competitive nature of glucose-ô-r inhibi­
tion of brain hexokinase with respect to ATP has since been confirmed 
by other authors (Grossbard and Schimke, 1966; Uyeda and Racker, 1965a; 
Copley and Fromm, 1967; Gerber et al., 1974; Rijksen and Staal, 1977). 
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If glucose-6-P is binding at the ATP site on the enzyme, this data elim­
inated the possibility that brain hexokinase operates with a ordered 
sequential mechanism with glucose binding first. However, the other 
possible ordered mechanism, that with MgATP adding first and glucose-
6-P released last, was not eliminated. 
The study of the effect of the other product, ADP, on the enzyme did 
not resolve the kinetic mechanism but rather displayed noncompetitive in­
hibition patterns with respect to both substrates (Fromm and Zewe, 1962a; 
Grossbard and Schimke, 1966; Kosow and Rose, 1968; Hanson and Fromm, 1965; 
Copley and Fromm, 1967; Purich and Fromm, 1971). This noncompetitive 
inhibition is noteworthy because most kinases displaying sequential 
kinetics are inhibited by ADP in a competitive manner with respect to 
ATP. 
In 1969, Ning et al. (1969) tried to distinguish between two pos­
sible mechanisms of ADP inhibition of hexokinase which could account 
for the noncompetitive nature of the inhibition. One mechanism placed 
the inhibitor across both the sugar and ATP loci within the binding site 
on the enzyme. This position would prevent the product from inhibiting 
the enzyme competitively with respect to either substrate. The second 
mechanism placed ADP at an allosteric site on hexokinase remote from the 
active site. The first mechanism was excluded by an experiment where 
first glucose and secondly ATP was held at saturating levels while the 
other substrate was varied in the presence of ADP. In both cases, the 
inhibition remained noncompetitive. It was reasoned that if ADP could 
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bind at either site, saturation of the enzyme with one substrate would 
make the inhibition competitive. If ADP bound across both substrate 
binding sites, saturation of the enzyme with one substrate should abolish 
the inhibition. Additionally, ADP showed multiple binding to the enzyme 
possibly indicating binding to a regulatory site as well as the active 
site. 
The kinetic mechanism of brain hexokinase was finally resolved by 
the use of substrate analogs as linear competitive inhibitors for the 
substrates of the hexokinase reaction (Fromm, 1975; Fromm, 1980). 
4-Using N-acetylglucosamine, ATP , and j3,"X-5 -adenylyl methylene diphos­
phate as substrate analogs, Ning et (1969) found kinetic patterns 
for the bovine brain enzyme that were fully consistent with a random 
ordering of substrates. Similar results have been obtained for the 
ascites tumor (Kosow and Rose, 1968) and rat brain (Purich and Fromm, 
1971) hexokinase. 
Additional evidence supporting random addition of substrate to 
hexokinase I comes from binding studies (Ellison et , 1975) , isotope 
trapping (Fromm and Solheim, 1977), and enzyme protection studies 
(Redkar and Kenkare, 1972; Redkar and Kenkare, 1975; Wilson, 1978; Wilson, 
1979). All of these, when taken together, indicate that each substrate 
interacts with the enzyme in the absence of other factors. 
Along with the study of the kinetic mechanism of brain hexokinase 
came the elucidation of the regulatory properties displayed by the 
enzyme. The potent inhibition of the enzyme by glucose-6-P has already 
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been alluded to. Another aspect of brain hexokinase regulation is the 
ability for inorganic phosphate to reverse this inhibition. This latter 
property, first observed in tumor cells by Teidemann and Born (1959), has 
also been observed in whole cells and cell homogenates (Rose, 1965), 
reconstructed glycolytic systems (Uyeda and Racker, 1965b), and in 
isolated hexokinase (Purich and Fromm, 1971; Rijksen and Staal, 1977; 
Shone and Fromm, 1980). Besides the effects of sugar-phosphate and 
inorganic orthophosphate, the activity of the enzyme may be regulated by 
the level of nucleotides present (Ning ejt al., 1969; Purich and Fromm, 
1971; Rijksen and Staal, 1977). Along with inhibition by ADP, brain 
hexokinase is inhibited by both guanosine di- and triphosphates in a 
noncompetitive manner with respect to either substrate. At higher 
concentrations pyrimidine nucleotides proved competitive inhibition of 
ATP binding (Ning al., 1969; Purich and Fromm, 1971). 
While the regulation of brain hexokinase by glucose-6-P and P_. has 
been established for some time, the mechanism of action of these effectors 
is a source of controversy. Most workers in this field believe that 
glucose-6-P regulates hexokinase activity by binding to an allosteric 
site on the enzyme. This mechanism was first proposed by Weil-Malherbe 
and Bone (1951) after they observed that glucose-6-P was a noncompetitive 
inhibitor (with respect to glucose) of hexokinase activity. Crane and 
Sols (1954) surveyed the effects of 25 sugar phosphates on hexokinase 
and found that very few were effective inhibitors of the enzyme. Most 
notable in their findings was that the 6-phosphates of good substrates 
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such as mannose, 2-deoxyglucose, and fructose did not inhibit the enzyme. 
Crane and Sols concluded that glucose-6-P bound at a site specific for 
this sugar-phosphate remote from the active site. The support for this 
idea comes from the unusual nature of the inhibition and from the dif­
ference in specificity between the active site for hexose and the 
inhibitory site for hexose-phosphate. In addition, the formation of a 
tightly binding E-glucose-glucose-ô-P abortive complex (Ellison et al., 
1975; Wilson, 1978) has been taken by some investigators as further evi­
dence for an allosteric site on brain hexokinase. Much support for this 
model of brain hexokinase regulation has been expressed in the litera­
ture (Colowick, 1973; Rose et al., 1974; Wilson, 1980) with the latest 
coming in a recent communication by Lazo _et al, (1980). Here the 
authors present evidence for multiple binding of glucose-6-P to brain 
hexokinase and they conclude that the sugar phosphate is binding to a 
high-affinity regulatory site and a low-affinity active site in the 
enzyme. However, several technical problems encountered by the authors 
during their investigations, plus the type of information yielded by 
static binding experiments, make the authors' observations inconclusive. 
The second model of brain hexokinase regulation was first proposed 
in 1962 when Fromm and Zewe (1962a) observed that glucose-6-P was a 
linear-competitive inhibitor of brain hexokinase with respect to MgATP. 
These authors felt that the effects of glucose-6-P on hexokinase could 
best be explained by placing the sugar-phosphate at the y-phosphate 
subsite within the ATP binding locus on the enzyme. The displacement of 
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the sugar phosphate from the glucose binding domain upon phosphoryla­
tion by ATP would allow addition of a second glucose molecule to the 
active site, and account for the formation of the E-glucose*glucose-
6-P ternary abortive complex. Support for this model is drawn from studies 
on glucose-6-P inhibition which show that only one inhibitor molecule 
binds per enzyme monomer, even at high (450 to 1000 pjM) levels of 
glucose-6-P (Grossbard and Schimke, 1966; Ellison et , 1975). Addi­
tional evidence comes from studies which indicate that mannose-6-P 
(Casazza and Fromm, 1976) and fructose-6-P (Rijksen and Staal, 1977) 
inhibit brain hexokinase with qualitatively the same mechanism as glucose-
6-P, but with a lower affinity for the enzyme. This observation is con­
trary to the findings of Crane and Sols (1954) and weaken their arguments 
for proposing a second site for glucose-6-P action. 
A third type of regulation which has been proposed for brain hexo­
kinase involves the partitioning of the enzyme between soluble and par­
ticulate states. This hypothesis arises from the observation that hexo­
kinase I is partitioned, in the brain, between soluble and mitochondrial 
bound pools of activity (Crane and Sols, 1953; Johnson, I960; Rose and 
Warms, 1967; Craven and Basford, 1969; Feigner et ^ ., 1979) and that 
metabolites in the cell such as glucose-ô-P and ATP promote release of 
hexokinase from the mitochondria while phosphate tends to retard the 
enzyme's release (Rose and Warms, 1967). Wilson (1968) proposed that the 
distribution of hexokinase activity was regulated by these metabolites, 
and decreases in their cellular concentrations, as during increased rates 
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of glycolysis, displaced the soluble-particulate equilibrium toward 
increased levels of the particulate form. Since the particulate form 
of the enzyme displays greater affinity for ATP, and is less inhibited 
by glucose-6-P (Wilson, 1968; Tuttle and Wilson, 1970), the increased 
proportion of particulate enzyme would allow maintenance of the higher 
rate of glycolysis. 
In an attempt to determine whether or not changes in the glucose-
6-P concentration in the cell can affect the distribution of hexokinase 
between the soluble and particulate state, Purich and Fromm (1971) 
evaluated ^  vitro the glucose-6-P potential for solubilization in the 
presence of "physiological" levels of enzyme, substrates, products, and 
effectors. The authors found that neither phosphate nor glucose-6-P 
was able to change the distribution of the enzyme even when present in 
excess of the reported "physiological" concentrations. More recent 
in vivo studies performed on chick (Knull et al., 1973) and mouse 
(Bachelard, 1976) have indicated that the distribution of hexokinase 
between soluble and bound forms does change in the brain during conditions 
of ischemia, but there is still no evidence that the partitioning of 
hexokinase changes under normal cellular conditions. 
While the kinetic mechanism and regulation of brain hexokinase have 
been investigated extensively, the chemistry of the active site of this 
enzyme has received attention only in the last few years. Most of the 
work in this area has pointed to the presence of thiol groups at or 
near the active site. Several thiols are available for modification 
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by 5,5'-dithiobis(2-nitroben2oic acid) (Redkar and Kenkare, 1972, 1975) 
while inactivation of the enzyme by tetranitromethane has indicated 
that the rapid loss of 2 cysteinyl residues accounts for the loss of 
activity (Subbarao and Kenkare, 1977a). In an attempt to define the 
location of the reactive thiols, Subbarao and Kenkare (1977b) treated 
the enzyme with the ATP analog 6-mercapto-9-/3-I>-ribofuranosylpurine 
5'-triphosphate. This reagent showed saturation kinetics in its inacti­
vation of brain hexokinase and, as it functions as a weak substrate 
(K = 0.25 mM), binding probably occurs at the active site. Both 
glucose and ATP protected the enzyme against inactivation. 
A more recent study (Swarup and Kenkare, 1980) has used the glucose 
analog, N-(bromoacetyl)-D-glucosamine as an active site probe for brain 
hexokinase. In this study, the modification of one thiol led to inacti­
vation of the enzyme. The reagent displayed both saturation and pseudo-
first-order kinetics with the enzyme. In addition, the analog was a 
competitive inhibitor of glucose binding. The enzyme was protected from 
inactivation by glucose and glucose-6-P, and, to a lesser extent, ATP. 
These studies provide good evidence that one or more essential thiols 
are located around the active site of the enzymej however, whether or 
not they are involved in catalysis of the hexokinase reaction or func­
tion in maintaining the active conformation of the enzyme is not yet 
clear. 
Few additional studies on the chemical nature of the hexokinase 
reaction have been attempted; however, one observation 
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deserves mention here. This involves the inactivation of brain and 
muscle hexokinase by xylose and ATP (Lazo and Sols, 1979). This reaction 
seems to be an irreversible autophosphorylation of the enzyme that leads 
to inactivation. While the reaction has not been well-characterized in 
mammalian isozymes, the similar reaction that occurs to the yeast isozyme 
(DelaFuente, 1970) is mediated through the phosphorylation of a serine 
residue, presumably at the active site of the enzyme (Menezes and Puddles, 
1976). 
The work presented in this dissertation addresses two aspects of the 
brain hexokinase problem. The first section attempts to probe the active 
site of the enzyme by the use of pH kinetics while the second section 
describes a procedure for the removal of aluminum and other metal ions 
from commercial preparations of ATP. This treatment of ATP is necessary 
because of the formation of an AlATP complex which inhibits brain hexo­
kinase at neutral pH. The final section of this dissertation probes the 
•mode of regulation of hexokinase by giucose-o-P. By studying the reverse 
reaction (Glucose-6-P + ADP —Glucose + ATP), an attempt is made to 
determine the location of glucose-6-P binding on the enzyme. This dis­
sertation presents research done by myself while under the direction of 
Dr. H. J. Fromm, and published under our joint authorship (Solheim and 
F r o m m ,  i 9 o O a ,  i 9 o 0 b ,  i y S l j .  
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SECTION I. pH KINETIC STUDIES OF BOVINE BRAIN HEXOKINASE 
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ABSTRACT 
The variation of kinetic parameters with pH was examined for bovine 
brain hexokinase with glucose and MgATP as substrates. The -log(V^) and 
-log(V^ /Km) profiles for both substrates were examined and seen to 
decrease below pH 6.5. All profiles asymptotically approached slopes 
of -1, indicating that the loss of activity in each instance was due to 
the protonation of a single group on the enzyme. Analysis of the data 
indicated that two ionizable groups were involved in the reaction. One 
functions in the binding of ATP and in catalysis, while the other partic­
ipates in the binding of glucose. The -log(V^) profiles both showed a 
"hump" attributed to a loss of activity in the pH region of 7.5 to 5.5. 
Addition of aluminum ions to the reaction mixture increased the magnitude 
of the hump, but the inhibition was abolished by the addition of citrate. 
Kinetic studies carried out at pH 7 indicated that aluminum was a com­
petitive inhibitor with respect to ATP, and noncompetitive with respect 
to glucose. However, secondary plots of the kinetic data were nonlinear, 
concave downward, indicating that the inhibition is not of a simple type. 
Possible explanations for this phenomenon are presented. 
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INTRODUCTION 
Brain hexokinase (hexokinase I) now is recognized as a primary 
control point of glycolysis in the brain. Because of its metabolic 
importance, much time and study have been devoted in attempts to 
acquire a thorough understanding of the kinetic mechanism of hexokinase 
(Purich et al., 1973). However, it has only been within the last few 
years that attention has been directed to the chemistry of this enzyme's 
active site. Recent studies have shown that sulfhydryl groups are 
required for activity in both yeast (Jones ^  al•> 1975; Otieno et al., 
1975) and mammalian (Redkar and Kenkare, 1972; Chou and Wilson, 1974; 
Subbarao and Kenkare, 1977a) hexokinase and there is some evidence to 
indicate that these groups are involved in the binding of substrate 
(Subbarao and Kenkare, 1977b). Carboxyl groups have been reported to be 
involved in the action of yeast hexokinase (Pho et aX,, 1974), and 
from x-ray crystallographic data, Anderson et al. (1978) have observed 
what seems to be an interaction between an aspartyl residue and the 
4- and 6-hydroxyl groups of the sugar substrate. There is evidence 
for the involvement of histidyl residues in the active site of the 
wheat germ enzyme (Higgins and Easterby, 1974), but this residue has 
been found not to be involved in either the binding of substrate or 
catalysis of yeast hexokinase (Grouselle et al., 1973). 
In this study, we have made use of pH kinetics to gain information 
about the groups responsible for binding and catalysis of substrate 
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molecules by bovine brain hexokinase. We report evidence for a single 
ionizable group involved in the catalysis of the reaction and in the 
binding of ATP, and a second residue that functions in the binding of 
the carbohydrate substrate. In addition, we offer observations on an 
anomalous loss of activity below pH 8 similar to the decrease reported 
in a recent paper by Viola and Cleland on the pH profiles of yeast 
hexokinase (Viola and Cleland, 1978). Colowick has suggested that this 
3+ 1 inhibition may be caused by the trivalent metal ion A1 . Our results 
indicate that this ion may indeed be responsible for the pH dependent 
activity loss. Kinetic evidence indicates that this inhibition is 
nonlinear competitive with ATP and may be due to the formation of a 
strongly inhibitory aluminum-ATP complex, as well as interactions of 
the metal with the enzyme alone. 
Dr. S. f. Colowick. frofessor of Microbiology, Vanderbilt University, 
Nashville, Tennessee, personal communication. 
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EXPERIMENTAL PROCEDURE 
Materials 
Glucose 6-phosphate dehydrogenase was purchased from Boehringer 
Mannheim. Buffers used in the experiments were from Calbiochem. ATP 
and NADP"^ were products of Sigma, and glucose was from Pfhanstiehl. 
Distilled-deionized water was used in the preparation of all reagents. 
All other chemicals were of the highest purity available commercially. 
Methods 
Bovine brain hexokinase was prepared by the method of Redkar and 
Kenkare (1972) and had a specific activity of 62 units/mg. A unit is 
defined as 1 pmole of glucose-6-P produced per minute at 28* in a total 
reaction volume of 3 ml under standard assay conditions. The standard 
assay contained 10 mM glucose, 5 mM ATP, 50 mM TRIS-CI (pH 7.6), 0.33 
zzM NAD?) 7 mM and 1.7 units of elucose-ô-r dehydrogenase in a 
total volume of 3.0 ml. 
The purified enzyme was stored as previously described (Redkar and 
Kenkare, 1972) and was desalted before each experiment on a Bio-Gel 
P-10 column, which had been equilibrated with 20 mM HEPES, pH 7.6, 
containing 5 mrl p-mercaptoethanol. The enzyme was found to be stable 
for at least 4 h after desalting. For initial rate studies, the enzyme 
was diluted into 1 mg/ml of bovine serum albumin. 
Kinetic assays were carried out in 1.0-ml volumes in 1-cm cuvettes 
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by using a Gary 1186 spectrophotometer with a water-jacketed cell 
compartment. All assays were carried out at 28® unless otherwise 
indicated. Assays were initiated by the addition of 0.003 to 0.02 
units of hexokinase. 
The buffers used for the profile were acetate, 2-(N-morpholino)-
ethanesulfonate (IIES), piperazine-N,N'-bis(2-ethanesulfonate) (PIPES), 
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonate (HEPES), 2-(cyclohexyl-
amino)ethanesulfonate (CHES), and 3-(cyclohexylamino)propanesulfonate 
(caps)- Each buffer was used within 1 pH unit of its pK value. The 
buffers had no effects upon activity when the enzyme was assayed in 
their presence at pH 7.6. Buffer concentrations were maintained at 
10 mM in each experiment and adjusted to an ionic strength equivalent 
to 10 mM salt by addition of KCl. 
Reaction rates were determined by measuring the conversion of 
NADP^  to NADPH in the glucose 6-phosphate dehydrogenase-hexokinase 
coupled assay. The coupling enzyme was dialyzed before use to remove 
ammonium sulfate. To verify that the rates measured were not limited 
by the coupling enzyme, various concentrations of hexokinase were added 
to assays containing a constant amount of glucose 6-phosphate dehydro­
genase at the different pH values used. The plot of velocity vs. 
hexokinase was linear. The amount of couple varied from 0.75 unit/ 
assay at pHs above 7.0 to 8.0 units/assay at pH 4.5. Each assay 
mixture contained 10 mM buffer, 0.4 mM NADP , and 2.5 mM Mg in excess 
of the concentration of ATP. In assays where ATP was varied, glucose 
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was held at saturating levels (2.2 mM). When glucose was the varied 
substrate, MgATP^ was saturating (10 mM). When this method is used, 
breaks in the -log(V^) profile will indicate groups ionizing in the ter­
nary complex, and breaks in the -log(Vj^ /K^ ) profiles will indicate groups 
ionizing from the EA complex where A is the saturating substrate. 
Other conditions were as stated in the figure legends. 
For the pH studies in the presence of dimethylsulfoxide (DMSO), 
only cationic buffers were used. At pH values below 5.5, MES buffer 
(pK 6.5 at 20°) was used in a concentration so as to maintain at least 
1.2 mM of the buffer in the neutral form. 
Atomic absorption analysis of ATP for aluminum was performed by 
the Ames Laboratory of the United States Department of Energy, Ames, 
Iowa. 
Contaminating aluminum was removed from ATP by extraction with 
2 8-hydroxyquinoline and chloroform. 
Initial rate data were analyzed and fit to specific models by the 
weighted least-squares method, assuming equal variance of velocities 
by a computer program written in the OMNITAB language (Siano et al., 
1975). The value of a was equal to zero. 
The data from the pH experiments were plotted according to the 
procedure of Dixon (1953), and were fitted by an unweighted nonlinear 
least squares regression to Eq. 1, where f is or Vi(app)/Ks(app) 
2 Section II. 
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at the pH studied, 
log(f) = log(C) - log 1 + 
n 
(1) 
and C is Vj^  or V^ /K^ . n represents the number of groups involved in 
a dissociation and was varied to obtain the best fit to the experimental 
data. is the apparent dissociation constant. For ease in computing, 
Eq. 1 was rearranged by combining the log terms on the right side of 
the equation arid multiplying the term within the log function by the 
quantity K^/K^ (Eq. 2). 
log(f) = log (Kg)"(C) (2) 
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RESULTS 
Studies of the variation of kinetic parameters with pH may provide 
information on the functional enzyme groups associated with binding and 
catalysis. Because information of this type is lacking in the case of 
brain hexokinase, experiments were undertaken in an attempt to gain 
insight into the mode of substrate interaction with this enzyme. 
Figures la and lb show Dixon plots for the pH-dependent variation 
of the maximal velocity (V^ ) and maximal velocity/K^ for 
varied ATP at a constant glucose concentration. As the pH was lowered 
below 6, a limiting slope of -1 was obtained, indicating that the 
protonation of one group on the enzyme was responsible for the loss of 
activity. Computer fitting of the data yielded pK's of 5.66 + 0.10 for 
the -log(Vj^) profile and 5.20 + 0.11 for the -log(V^/K^^) profile. No 
decrease in velocity was seen at basic pH values. 
Between the pH values of 7.5 and 5.5. there is a decrease in 
activity which appears as a "hump" in the -log(V^ ) profile (curve a 
of Fig. 1). This loss of velocity is similar to that seen by Viola 
and Cleland (1978) in their study of the pH kinetics of yeast hexokinase. 
They found that citrate activated the enzyme in this pH region and 
speclated that this phenomenon may be related to the citrate activation 
of yeast hexokinase below pH 7 reported by Kosow and Rose (1971). In 
the fitting of the data, the values constituting the hump were omitted 
from the data file. When the experiments were repeated with aluminum-
free ATP, profiles superimposable on the theoretical curves generated 
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in Fig, 1 were obtained. In accord with the profiles in Fig. 1, the 
data gave the best fit to Eq. 2 when one group was assumed to dissociate. 
The pH profiles generated with glucose as the varied substrate are 
shown in Fig. 2. Curve a of this graph shows the -log(V^ ) profile at 
28°. As was the case with varied ATP, as the pH was lowered, the slope 
of the line asymptotically approached a slope of -1 within the pH range 
studied. Computer fitting of the data gave a pK of 5.85 + 0.05. In 
the pH range from 7.5 to 5.5, a loss in activity resulting in a hump 
was again observed. These values were omitted from the computer fit. 
Curve c of Fig. 2 displays the -logCV^ /Kg^ ^^ g^^ ) profile at 28°. The 
curve was fitted assuming one group was involved in the protonation. 
The computer determined value of the pK is 5.47 + 0.14. These experi­
ments were also repeated with aluminum-free ATP and showed no signifi­
cant variation from the theoretical curves shown in Fig. 2. The best 
fit was obtained when n = 1. 
To investigate the identity of ths groups being prctcnated, the 
variation of pK with temperature was determined for each of the profiles. 
For the -log(V^) profile with the varied ATP, the determined pK's were 
5.96 + 0.06 at 20°, 5.66 + 0.10 at 28°, and 5.57 + 0.08 at 35°. The 
value for as estimated from the slope of the van't Hoff plot, is 
10 ± 2 kcal/mol. The values of the pK*s in the -log(V^/K^^) profiles when 
ATP concentration was varied were 5.34+0.11, 5.20+0.12, and 5.06 
+ 0.09 at 20°, 28°, and 35°, respectively. The AH. value for this 
— ion 
group is 8 + 2 kcal/mol. Both of these values (8 and 10 kcal/mol) 
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are much too large to account for the energy required for a simple 
carboxyl ionization, but they are consistent with the involvement of a 
histidyl residue — 7 kcal/mol). 
The pK's at the various temperatures for the -log(Vj) profile with 
varied glucose concentrations are 5.96 + 0.10 at 20®, 5.85 + 0.05 at 
28°, and 5.71 + 0.05 at 35°. As expected, the pK's decreased with 
increasing temperature. The value, 7+2 kcal/mol, again indicates 
the possible involvement of a histidyl residue in the catalytic process. 
Curves b, c, and d of Fig. 2 display the -logCV^/K^^^^^gg) profiles 
at 35°, 28°, and 20°, respectively. The determined pK's at these 
three temperatures are 5.45+0.15, 5.47 +0.14, and 5.53 + 0.07 at 
3 5 ° ,  2 8 ° ,  a n d  2 0 ° ,  r e s p e c t i v e l y .  T h e  v a l u e  f o r  a t  o n l y  2 + 2  
kcal/mol, is much less than that required for the ionization of a 
histidyl residue, and is only a little higher than the + 1.5 kcal/mol 
required to ionize a simple carboxyl group. This is clearly a different 
group frc= that involved in catalysis or in the binding of ATP. 
Additional evidence on the nature of the ionizing groups was 
obtained by observing the change in kinetic parameters with respect to 
pH in the presence of organic solvent. Dimethylsulfoxide (DMSO) was 
added to the reaction mixture to give a final concentration of 25% 
(vol/vol), and the pH profiles were generated for both varied ATP and 
glucose. The buffers used in these experiments were of the cationic 
type. Since dissociation of a proton from this type of buffer does 
not increase the net quantity of charged species in solution, lowering 
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the dielectric constant of the system by inclusion of an organic 
solvent will not effect the pK of the buffer. If buffers of the neutral 
acid type were used, the shift in the equilibrium of the system toward 
uncharged species caused by the lowering of the dielectric constant 
would produce an apparent shift in the pK of the buffer toward more 
basic pH values. This same effect is reflected by the ionizable groups 
within the enzyme. If the experiment is done in a cationic buffer, 
the pK of a histidyl group on the enzyme will not be changed by inclusion 
of an organic solvent in the system, while the pK of a neutral acid 
group will be raised. Similarly, if the experiment is performed in a 
neutral acid buffer, the pK of histidyl residues will become more 
acidic and the pK of neutral acid groups will not vary (Findlay et ad., 
1962; Inagami and Sturtevant, 1960). 
Table I shows the results of the DMSO experiments. While the 
pK's for the kinetic parameters did not vary with varied ATP or with 
the log(V,) profile with varied glucose concentration, the pK for the 
log(V,/K , ) profile shifted about 0.3 pH units toward the basic 1 glucose 
end of the pH range. Although this change is somewhat small, it tends 
to support the view that this group is a carboxyl. The data for the 
other kinetic parameters are in harmony with the ionizing group(s) 
being one or more histidyl residues. 
In 1971, Kosow and Rose (1971) reported the activation of yeast 
hexokinase by citrate and other ions at pH values below 7. This 
activation was reduced if reagents were passed through a Ghelex column 
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before use. More recently, Viola and Cleland (1978) have shown that 
a pK dependent loss of activity by this same enzyme can be restored by 
the inclusion of citrate in the reaction mixture. Colowick has 
indicated that this inhibition may be due to aluminum ions present 
with the ATP in the reaction mixture and can be reversed by citrate, 
EDTA, and phosphate.^ 
Atomic absorption analysis of the ATP used in these experiments 
(Product No. A-2383, lot No. 96C-7170, by Sigma) indicated that aluminum 
was indeed present in this preparation at a concentration of 190 ppm. 
This is equivalent to a concentration of 1.08 aluminum in a 0.25 mM 
solution of ATP. Our first attempt at demonstrating aluminum inhibition 
with hexokinase indicated that approximately 15 M aluminum was required 
to produce 50% inhibition of the enzyme, much more than present in ATP. 
However, when we preincubated the aluminum with the stock ATP solution 
for 30 min., we observed significant inhibition of the enzyme with 
microsolar concentrations of aluminum. 
Figure 3 shows the results of an experiment in which the added 
aluminum was preincubated with 2.5 mM MgATP before addition of the ATP 
to the reaction mixture. Curve a of Fig. 3 indicates that at pH 7, and 
when preincubated with ATP, aluminum inhibits brain hexokinase at micro-
molar concentrations. If one takes into account the aluminum already 
^Dr. S. P. Colowick, Professor of Microbiology, Vanderbilt University, 
Nashville, Tennessee, personal communication. 
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contained in the ATP (190 ppm), the concentrations expressed on the 
abscissa are all increased by 1 and the inhibition line is offset 
one unit to the right (broken line). The intercept of the broken line 
(the apparent of the line) is close to that for the velocity 
of hexokinase at pH 8 (line d). The concentration of aluminum required 
to cause 50% inhibition of the enzyme is then approximately 2.5 /xM. 
Curve b of this figure demonstrates the effect of aluminum on hexokinase 
when 1 mM citrate has been included in the system. At the concentrations 
investigated, aluminum had no inhibitory effect. Curves c and d of 
Fig. 3 indicate the effects of aluminum and citrate on the enzyme at 
pH 8. In curve d, all conditions except pH are identical with those in 
curve a. Curve c indicates that the assay system contains 1 mM citrate. 
Curves c and d show that at pH 8, aluminum is unable to inhibit the 
enzyme, and citrate does not activate it. 
To determine the effect of aluminum over the range of the pH 
profile, the effect of pK on the kinetic parameters of brain hexokinase 
was redetermined in the presence of added aluminum, and in the presence 
of added aluminum and citrate. Figure 4 shows the results of this 
experiment. Curve a of this figure indicates the effect of increasing 
the aluminum content of the ATP to 400 ppm. The added aluminum was 
preincubated for 30 min. with 50 mîi ATP before addition of the nucleotide 
to the reaction mixture. A comparison of this profile to curve a of 
Fig. 1 shows that doubling the aluminum contamination of the ATP causes 
a 0.3 log unit change in the profile in the pH range between 7.5 and 
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5.0 and makes estimation of the pK almost impossibe. 
Curve b of Fig. 4 was generated using conditions identical to 
those in curve a except for the inclusion of 1 mM citrate in the assay. 
All evidence of the hump has been removed, and the typical profile of 
the Dixon plot is observed. Computer fitting of these data gave a 
pK of 5.71 + 0.10, which agrees well with the value initially determined 
in the absence of citrate, 5.66 + 0.10 (Fig. 1, curve a). 
In an effort to determine the mode of action of aluminum on 
hexokinase, we attempted to reverse the aluminum inhibition by the 
2+ 2+ 
addition of Mg to the reaction mixture (Fig. 5). The Mg concentra­
tion was varied from 1 to 10 mM in the absence and presence of added 
2+ 
aluminum. The added Mg did not have the ability to lessen the 
aluminum inhibition. 
Figures 6 and 7 show double reciprocal plots of velocity vs. 
varied ATP and glucose concentrations, respectively, at different, 
fixed levels of A1(N0„)„. The data show that aluminum is a competitive 
inhibitor of ATP and a noncompetitive inhibitor of glucose. The 
secondary plots (see insert of Fig. 6) for slopes in the 1/v vs. 1/ATP 
plots and for slopes and intercepts in the 1/v vs. 1/glucose plots 
(data not shown) vs. AlCNOg)^, are nonlinear, concave downward. 
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DISCUSSION 
The results of studies of pH changes on enzymatic activity are often 
difficult to interpret. To draw valid conclusions about the identity 
of ionizing groups involved in the enzymatic process, several types of 
data must be compared. To this end, three types of observations were 
compiled in this study, the pK's of the ionizing groups affecting 
activity, the changes in these pK's with changing temperature, and the 
affect of organic solvent on the pK values. 
The Dixon plots generated from the data gave relatively simple 
profiles with limiting slopes approaching -1 on the acid side of the 
pH scale. No variation in activity was observed at basic pH values. 
Computer analysis of the data gave the best fit to the theoretical 
curve when the ionization of one group was assumed to be responsible 
for the loss of activity in each profile. These groups can be broken 
down into two tvpes, cationic grouos with large An. values, and a 
- - - - xon 
neutral acid group with little dependence upon temperature for ionization. 
Table II gives a summary of the results obtained in these investigations. 
Three of the profiles, those for varied ATP concentrations and 
the -log(V^ ) profile for varied glucose concentration, were caused 
by a cationic group, and a neutral acid residue was responsible for 
the change in parameters on the -logCV^ /K^ ^^ ^^ g^ ) plot. These results 
can most simply be interpreted in terms of two ionizing groups on the 
enzyme. The first is involved in the binding of MgATP to the enzyme 
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and the breakdown of the ternary complex (E-GlcMgATP) to products. 
This residue has a pK around 5.7 in the ternary complex and 5.2 in the 
free enzyme. The high value, and the observation that organic 
solvent does not shift the pK to more basic pH values, lends credence 
to the suggestion that a histidyl residue acts in this capacity. The 
0.5 pH unit variation between the pK's could be caused by conformational 
changes that occur in the enzyme upon binding of the substrate. Wilson 
(1978) has demonstrated such changes in conformation by studies of the 
rate of inactivation of rat brain hexokinase by chymotrypsin and 
glutaraldehyde in the presence and absence of substrate, and McDonald 
et al. (1979) and Pickover et al. (1979) have shown similar changes 
in conformation with yeast hexokinase and phosphoglycerate kinase and 
have speculated that this is a general phenomenon in kinase reactions. 
Alternatively, the variation in pK could indicate that separate histidyl 
residues are involved in the binding of ATP and the catalysis of the 
reaction. One or both of these residues may be remote from the active 
site of the enzyme and function by maintaining the active conformation 
of the enzyme. 
The second ionizable group implicated by these studies participates 
in the binding of glucose to the enzyme. This group appears, by its 
lov7 value, to be of the neutral acid type, and this conclusion is 
reinforced by the shift of its pK 0.3 unit towards the basic end of 
the pH scale in the presence of organic solvent. This residue is most 
likely aspartate or glutamate and may function by hydrogen bonding 
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with a hydroxy1 group of the sugar substrate. Although the pK for this 
group is approxiûiately 1.5 pH units higher than that of free aspartate 
or free glutamate, hydrophobic residues in close proximity could easily 
perturb its pK by this much. 
The effect of aluminum ions on brain hexokinase is difficult to 
explain and is complicated by the characteristics of aluminum in solu­
tion. Evidence shows that, at both acid and basic pH values, aluminum 
forms polymeric complexes with water and hydroxides (Akitt e£ , 1972; 
Mesmer and Baes, 1971). This could explain why aluminum only inhibited 
the enzyme in the pH range of 7.5 to 5.5. Outside of this range the 
aluminum may assume a polymeric form that is not inhibitory. The 
inclusion of 1 mM citrate in the reaction reversed the aluminum inhibi­
tion, presumably by complexing the aluminum ions. A comparison of the 
pK values determined in the absence and presence of 1 mM citrate 
(5.66 + 0.10 and 5.71 + 0.10) shows that the aluminum inhibition did 
not affect the analysis of the data as long as the values between pH 
7.5 and 5.5 were omitted from the computer fit. 
The site of action of aluminum is not clear. The metal could form 
2+ 
an inhibitory complex with ATP (a strong complex since Mg was not 
able to reverse the inhibition), or it could bind directly to the enzyme. 
Since the inhibition by aluminum is potentiated when it is preincubated 
with ATP, an AlATP complex is likely to be the inhibitory species. 
This complex must have a high affinity for the enzyme, however, because 
it is present at approximately 0.5% of the concentration of ATP. The 
39 
high affinity of hexokinase for CrATP (Donenberg and CIeland, 1975) 
suggests that this is likely. 
The kinetic experiments presented in Figs. 6 and 7 lend credence 
to an AlATP complex being responsible for the inhibition of hexokinase 
as it is a competitive inhibitor of ATP and a noncompetitive inhibitor, 
of glucose. The nonlinear secondary plot, however, indicates that this 
is not inhibition of a simple type. 
Brain hexokinase is thought to operate by using a rapid equilibrium 
random mechanism (Ning et al., 1969; Bachelard et al., 1971; Gerber 
et al., 1974). The generalized equation for competitive inhibition in 
this mechanism is expressed in Eq. 3, where A in this case represents 
ATP, B is glucose, and I is the inhibitor, in this case aluminum. 
In linear competitive inhibition the exponent of I is one, and the 
replots are linear. If the inhibitor binds multiply to the enzyme, 
the exponent, n, becomes 2 or higher, yielding replots that are concave 
upward. If the stoichiometry of inhibitor binding is less than one, 
n will be less than one, and the secondary plots will be nonlinear 
concave downward as is seen in this case. The kinetic data presented 
in Figs. 6 and 7 were fitted to Eq. 3 by the OMNITAB program (Siano 
^ , 1975) with a variety of n values, and the exponent on the 
inhibitor term was found to be around 0.75. 
(3) 
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This effect could be explained in several different ways. One 
3+ 
could be that A1 ions form a complex with more than one enzyme mole-
3+ 
cule. If, for example, two molecules of enzyme complex with one A1 , 
an I term would be introduced into the rate equation. More complicated 
expressions would arise if the complex formed with a different stoi-
chiometry and could yield exponents of I varying from 0 to 1. If such 
a complex is formed, it may be possible to identify it by determining 
3+ 
the molecular weight of brain hexokinase in the presence of A1 . A 
large change in the weight of the enzyme would indicate complex forma­
tion and might allow a determination of the binding stoichiometry. 
A second possibility could be that the inhibitor molecule undergoes 
a concentration-dependent reaction that modifies it into a noninhibiting 
form. This is most easily visualized by imagining that the inhibitor 
undergoes a dimerization reaction (Eq. 4). If this happens, 
21 ^  Ig (4) 
I = I + 2I„ (5) 
o z 
-K + (K^  + 8K I (6) 
J = 4 ^ 
the added inhibitor (1^ ) will be partitioned between I and I2 (Eq. 5), 
and the concentration of I would be expressed as in Eq. 6 where K is 
the dissociation constant of the dimsr. If I is inhibiting and I- is 
not, the effect of the dimerization would be to reduce the apparent 
inhibition caused by an added amount of inhibitor. The formation of 
such complexes of aluminum is well-documented. Akitt et (1972) 
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have shown that when dissolved in water, AlClg'6H20 partitions between 
3+ 4+ 
the two forms AlCH^O)^ and Al2(0H)2(H20)g . As the pH of the solution 
is raised, higher order complexes of aluminum form, such as Alj^ ^^ (^0^ )24 
^^ 2*^ 1^2^ ^ and Alg(0H)2Q(H20)^^"'" (Akitt e^ , 1972). Other investi­
gators have found species such as Al2(0H)2^  ^and Al^ (OH)^  ^present 
8+ in solution at acidic pH and more complex forms such as Al^^(OH) 
in alkaline solution (Mesmer and Baes, 1971). 
The data presented here support the idea that aluminum is respon­
sible for inhibition of hexokinase below a pH of approximately 8.0. 
The inhibition is potent and can be reversed by citrate. Above pH 8.0, 
no inhibition by Al(NOg)g is observed, but this could be due to the 
characteristics of aluminum ions to form polymers at basic pH values. 
A paper by Womack and Colowick (1979) has appeared since preparation 
of the current study for publication. Their findings suggest that 
aluminum is a proton-dependent inhibitor of yeast hexokinase, and acts 
by complexation of AT? to form an inhibiting species. They also show 
that, while aluminum will inhibit rat brain hexokinase, it has little 
effect on rat muscle hexokinase or rabbit phosphofructokinase, and it 
was not an inhibitor of yeast glucokinase from Saccharomyces cerevisiae. 
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Table I 
Effects of DMSO on the pK of Hexokinase 
a 
Computer determined pK's for varied ATP and varied glucose in the 
absence and presence of DMSO. In the ATP varied experiment, glucose 
2-
was held at 2.2 mM and MgATP was varied from 0.25 mM to 2.0 mM. 
2-
When glucose was varied (from 0.02 mM to 0.1 mM) MgATP was held at 
10.0 mM. DMSO was added to a final concentration of 25% (vol/vol). 
All assays were carried out at 28°. 
Varied Substrate Kinetic pK in the absence pK in the presence 
Parameter of DMSO of DMSO 
MgATP^ " 5.66 + 0.10 5.71 + 0.06 
V,/K,_ 5.20 + 0.12 5.18 + 0.08 
i Air — — 
Glucose V, 5.85 + 0.05 5.81 + 0.09 i — — 
V,/K , 5.47+0.15 5.76+0.12 1 glucose - -
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Table II 
pK's of Catalytically Important Groups in Brain Hexokinase 
Varied Substrate Kinetic pKa 
Parameter 
MgATP^ " 5.66+0.10 10 kcal/mol 
Vi/Katp 5.20+0.12 8 kcal/mol 
Glucose V, 5.85 +0.05 7 kcal/mol i — 
V,/K , 5.47 + 0.14 2 kcal/mol 1 glucose 
Figure 1. Dixon profiles generated with varied MgATP. 
(a) Plot of -log(V^ ) vs. pH with 2.2 mM glucose and 
2-
MgATP varied from 0.25 mM to 2.0 mM. Individual 
points represent computer fits of initial rate data. 
The pK, determined by computer fit to Eq. 2, is 
5.66 + 0.10. 
(b) Plot of -log(V^ /Km) vs. pH. The conditions are 
the same as in la. The pK is 5.20 + 0.11. 
Experiments were carried out at 28°. Other conditions 
are as stated in the experiniental section. The cur^ /es 
through the data are the computer-determined fits, 
assuming one ionizing group with the pK's given. 
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Figure 2. Dixon profiles generated with varied glucose. 
(a) Plot of -log(V^ ) vs. pH. MgATP^  held constant 
at 10.0 mM, glucose is varied from 0.02 mM to 0.1 
mM. Individual points represent computer fits of 
initial rate data. A computer fit of the data to 
Eq. 2 yielded a pK of 5.85 + 0.05. 
(b) Plot of -log(Vj,/Km) vs. pH. The conditions are 
the same as in Fig. 2, line a. The profile was 
taken at 35°. 
(c and d) Plots of -log(V^ /Km) vs. pH. The conditions 
are as above. Line c was determined at 28°and 
line d at 20°. 
Other conditions are as stated in the experimental 
section. The curves through the data were determined by 
nonlinear fitting to Eq. 2 assuming one group was 
responsible for the activity loss. 
"Log( V-] /Kgiycose^ -Log(Vi)  
Q. 
"o , 
T " 
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Figure 3. Plot of 1/velocity (V) vs. aluminum at pH 7 and 8. 
Glucose was held at 2.2 mM and MgATP at 0.25 mM. 
The buffer at both pH values was 10 mM HEPES. A 
ten-fold concentration of aluminum was preincubated 
with 2.5 mM ATP for 30 min. before 0.1 ml of this 
solution was added to complete the 1.0-ml assay 
mixture. The aluminum concentrations on the abscissa 
are the concentration of aluminum added in the assay. 
(a) 1/V vs. [aluminum] at pH 7. The broken line 
indicates the inhibition if the aluminum present 
in the ATP is included in calculating the final 
concentration of aluminum in solution. 
(b) 1/V vs^ . Taluminumj at pH 7. The conditions 
are as in line a but 1 mM citrate was included in 
the assay. 
(c) 1/V vs. [aluminum] at pH 8 plus 1 mM citrate. 
(d) l/V vs. [aluminum] at pH 8 minus citrate. 
1/V is expressed in (molar/min) 
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Figure 4. Dixon profiles generated In the presence of added aluminum 
and citrate. 
(a) Plot of -log(Vj^ ) vs. pH. The conditions are as 
in Fig. 1. Glucose was held at 2.2 mM and ATP was 
varied from 0.25 mM to 2.0 mM. Aluminum nitrate 
was added to the ATP to increase the contamination 
to 400 ])pm and was preincubated with 50 mM ATP 
before addition to the assay mix. 
(b) Plot of -log(V^ ) vs. pH. The conditions were 
identical to line a, except that 1 mM citrate was 
included in the assay. 
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Figure 5. Profile showing the effect of increasing Mg" on the 
3+ inhibition caused by 15 /iM A1 . Assays contained 
2.2 mM glucose, 2 mM MgATP^  , and were done at pH 7 
in 10 mM HEPES buffer. Magnesium was varied from 
1.0 to 10.0 mM in excess of the concentration of 
ATP. (A) 15 fiM aluminum nitrate added, (•) no added 
aluminum. 
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Figure 6. Plot of the reciprocal of the initial velocity vs. the 
2-
reciprocal of the molar concentration of MgATP in the 
absence (•) and presence of 10.0 fxM (•) and 20.0 jxM 
(A) AKNOg)^ . Glucose was held at 0.03 mM and MgATP^  
was varied from 0.2 to 1.0 mM. The assays were done at 
28° in 10 mM HEPESbuffer, pH 7.0. 1/ATP is in (molar)"^  
and 1/V is expressed in (molar/mir.)"". 
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1/ATPMO"^ 
Figure 7. Plot of the reciprocal of the initial velocity vs. 
the reciprocal of the molar concentration of glucose 
in the absence (•) and presence of 15 pM (A) and 
30 fiM (•) AlCNOg)^ . MgATP^ " was held at 0.31 mM 
while glucose was varied from 0.02 mM to 0.10 mM. 
Assays were carried out at 28° in 10 mM HEPES 
buffer, ph 7.0. 1/V is expressed in (molar/min) ^  
and 1/Glucose is in (molar) ^ . 
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SUMMARY 
Commercial preparations of ATP are contaminated with aluminum, a 
potent inhibitor of both brain and yeast hexokinase at neutral pH 
(Womack, F. C., and Colowick, S. P. (1979) Proc. Natl. Acad. Sci. U.S.A. 
76, 5080-5084 and Solheim, L. P., and Frotrnn, H. J. (1980) Biochemistry 
19, 6074-6080). In an effort to remove this ion, we have developed an 
extraction procedure that eliminates more than 99% of the contaminant 
with no loss of nuceotide. The method involves repeated extractions 
of the nucleotide solution with 8-hydroxyquinoline in chloroform, 
followed by one extraction at higher pH, that removes the final 10% of 
the aluminum contaminant that seems to be sequestered in a slowly 
dissociating complex and is unavailable to the 8-hydroxyquinoline at 
low pH. 
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INTRODUCTION 
It is now clear that aluminum has a profound influence on the 
enzyme hexokinase (Womack and Colowick, 1979; Solheim and Fromm, 1980). 
The observations that yeast hexokinase is activated by ethylenediamine-
tetraacetate (EDTA) and citrate (Kosow and Rose, 1971) and that the 
enzyme exhibits hysteresis (Shill and Neet, 1974), are most likely a 
manifestation of inhibition by aluminum (Morrison, 1980). 
We recently undertook kinetic experiments with brain hexokinase in 
which initial rates were monitored as a function of pH to gain some 
insight into the nature of those acid-base groups associated with the 
catalytic and substrate binding processes (Solheim and Fromm, 1980). 
The results that we obtained were qualitatively similar to those described 
by Viola and Cleland (1978) with yeast hexokinase. As did these investi­
gators, we also found that the anomalous V and V /K versus pH 
° max max m 
profiles could be "normalized" by addition of either EDTA or citrate 
(Solheim and Fromm, 1980). Analysis of our commercial ATP samples 
indicated that they contained 191 ppm (g/g) aluminum (Solheim and Fromm, 
1980). We found that this low level of the contaminating metal was, 
in fact, enough to cause those strange effects with hexokinase reported 
in the literature (Kosow and Rose, 1971; Shill and Neet, 1974; Viola 
and Cleland, 1978). 
To investigate the role of aluminum in the hexokinase reaction, it 
was necessary for us to eliminate the metal from our commercial samples 
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of ATP. We have developed a very simple and innocuous extraction pro­
cedure for the removal of aluminum from ATP that takes advantage of the 
very high stability constant of aluminum-8-hydroxyquinoline and its 
solubilty in chloroform. This report details the procedure. 
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MATERIALS AND METHODS 
NADP"^  was a product of Sigma. Glucose 6-phosphate dehydrogenase 
was purchased from Boehringer Mannheim, and glucose was from Pfhanstiehl. 
8-hydroxyquinoline was of reagent grade and was recrystallized 3 times 
from water before use. ATP samples were from Sigma. ATP product 
A2382, lots 119c-7600 and 116c-7110, and product A3377, lot I25c-7320, 
were used in these experiments. Distilled water, passed through two 
ion exchange columns, was used in the making of all reagents. Brain 
hexokinase was prepared by the method of Redkar and Kenkare (1972) and 
had a specific activity of 62 units/mg. 
ATP concentrations were determined spectrophotometrically by a 
coupled assay using hexokinase and glucose 6-phosphate dehydrogenase 
(Fromm and Zewe, 1972). ADP was assayed with lactate dehydrogenase and 
pyruvate kinase (Wellner et , 1966). All measurements were made by 
using a Gary 118C spectrophotometer with a water-jacketed cell compart­
ment. 
Analysis of ATP samples for aluminum was performed by atomic adsorp­
tion spectroscopy at the Analytical Service Division of the Ames Labor­
atory of the United States Department of Energy, Ames, Iowa. 
The extraction procedure was typically performed on 1 g= of ATP. 
The sample was dissolved in 10 ml of water, and the pH of the solution 
was adjusted to between 8 and 10 with 1 N sodium hydroxide. 10 ml of 
0.1 M 8-hydroxyquinoline in chloroform were added to the ATP solution. 
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and the two were mixed either by a magnetic stirrer or by a vortex 
shaker for 5 min. After mixing, the layers were allowed to separate, 
and the chloroform phase was removed and viewed under ultraviolet light 
for fluorescence. This procedure was repeated until the fluorescence 
of the chloroform phase was significantly diminished. This usually 
occurred within 7 extractions. On the next extraction, while the solu­
tions were mixed, the pH of the mixture was raised with 1 N sodium 
hydroxide until the solution toe!-, on a green color, indicating a parti­
tioning of the 8-hydroxyquinoline between the water and chloroform layers. 
After being shaken for 30 sec., the pH of the mixture was lowered with 
1 N HCl until the green color disappeared. The ATP solution was then 
extracted twice more with 8-hydroxyquinoline, followed by two extractions 
with chloroform to remove traces of the chelating reagent from the water 
phase. The ATP solution was then concentrated by lyophilization or 
used directly. 
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RESULTS AND DISCUSSION 
8-hydroxyquinoline is known to react with over 50 metals, generally 
those that form hydroxy- and amino-complexes. Most of these complexes 
are soluble in chloroform and show absorbances above 375 nm. Further­
more, complexes of aluminum, gallium, and indium fluoresce in the chloro­
form phase. Because very small quantities of metal cause strong fluo­
rescence, this property has been used for the detection of these metals 
in solution (Stary, 1964). The high affinity of 8-hydroxyquinoline for 
metal ions and its ease of extraction from solution made the reagent an 
obvious choice to remove the aluminum contaminant associated with commer­
cial preparations of ATP. This contaminant is believed to cause the 
anomalous kinetics associated with yeast and brain hexokinase at neutral 
pH (Womack and Colowick, 1979; Solheim and Fromm, 1980; Morrison, 1980). 
The kinetic data for both yeast and brain hexokinase indicate that 
alijminuTn. is not inhibitory above pK 8 (womack and Colowick, 1979; Solheim 
and Fromm, 1980). Aluminum also is known to form polynuclear complexes 
at basic pH. These observations led us to believe that there was a 
fundamental difference between the interaction of aluminum and ATP at 
neutral and basic pH values, and we decided to attempt to remove the 
aluminum contaminant from the nucleotide at these higher pK values. 
Table I shows our success at purifying 3 different samples of ATP 
obtained from Sigma. We found that there was a large variance in alu­
minum content between different products (determinations 1 and 3) and 
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between different lot numbers of the same product (determinations 3 
and 5). Initial attempts to remove the aluminum contaminant by repeated 
extraction with 8-hydroxyquinoline in chloroform indicated that from 
80% to 90% of the ion was removed in 3 or 4 extractions (determinations 
2, 4, and 6), but doubling the number of extractions did not remove sig­
nificantly more contaminant (determination 7). Furthermore, we observed 
a discoloration of the water phase of the mixture, which increased with 
repeated extraction of the nucleotide solution. The discoloration was 
weakly fluorescent under ultraviolet light and was unextractable with 
chloroform. 
We believe that this discoloration and weak fluorescence represent 
the remaining 10% of the aluminum in the sample, either still combined 
with ATP in a slowly dissociating complex or in some other way rendered 
inaccessible to the 8-hydroxyquinoline. We attempted to remove the 
remaining aluminum by two different procedures, both of which were 
succassful. First, ir.cubatsd the nucleotide solution overnight at 
room temperature to allow any slow dissociation to equilibrate before 
extraction. This procedure, shown in determination 8, allowed extraction 
of 98% of the contaminating aluminum. Second, if the remaining aluminum 
was complexed with ATP, then a shifting of pH toward the basic end of 
the pH scale could speed the breakdown of the complex. Furthermore, 
at increased pH, 8-hydroxyquinoline becomes ionic and soluble in the 
water phase of the mixture. To achieve this end, we increased the pH 
of the solution to approximately 12 with sodium hydroxide during an 
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extraction. The water phase of the solution became green as the solu­
bility of 8-hydroxyquinoline increased. After 30 sec. of mixing, the 
pH was lowered to between 8 and 10 with HCl, and the mixing continued 
for 5 min. When the phases separated, we observed that the discoloration 
of the water layer had abated and that it was no longer fluorescent 
under ultraviolet light. Determinations 9, 10, and 11 show the results 
of this procedure with various numbers of extractions performed before 
raising the pH. In each instance, 99% or more of the contaminant was 
removed. 
Quantitation of the yield of the extraction procedure indicated 
that no ADP was generated during the procedure. Yield, in terms of 
initial ATP, ranged from 89% to 95%, depending upon how carefully the 
water and chloroform phases were separated between extractions. Losses 
in product are due entirely to manipulation of the sample. 
The method itself is quick and easy to perform. Several samples 
can be treated in a few hours, and gram quantities of nucleotide can be 
handled in a single sample. Besides aluminum, other contaminating metal 
ions are likely to be removed from solution inasmuch as 8-hydroxyquino­
line has a strong affinity for many other metals under these conditions 
(Stary, 1964). 
To demonstrate the effect of the purified ATP preparation on the 
activity of brain hexokinase, we generated the pH profile with commer­
cial ATP and with ATP that had been freed of aluminum by the extraction 
procedure. Fig. 1 shows the Dixon profile (Dixon, 1953) of this exper­
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iment. When commercial ATP is used in the generation of the profile, 
an anomalous hump is present in the pH region 7.5 to 5.5. Because this 
is in the region of the pK for hexokinase (Solheim and Fromm, 1980), 
estimation of pK is uncertain. A similar finding was made with yeast 
hexokinase by Viola and Cleland (1978). When the purified ATP prepara­
tion is used to generate the same profile, all points lie close to the 
theoretical curve, and the normal profile of the Dixon plot is observed. 
The advantages of this procedure are many. It is simple, rapid, 
and avoids harsh conditions. It quantitatively removes aluminum from 
the sample and leads to little loss of the nucleotide. Besides aluminum, 
this procedure should be useful in removing other metals from nucleo­
tide preparations. 
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Table I 
Effect of 8-Hydroxyquinoline Extraction on 
Aluminum-contaminated ATP 
The concentration of aluminum in ATP was determined by atomic ad­
sorption spectroscopy before and after extraction with 8-hydroxyquinoline 
in chloroform. Each sample consisted of 1 g. of ATP dissolved in 10 ml 
of water. After extraction, each sample was concentrated by lyphiliza-
tion before analysis. 
Deter. ATP Sample No. of 
extract. 
Aluminum® 
(ug/ml) 
Fraction 
removed 
1.  lot 125C-7320 0  11.06 0 .0  
2 .  3  1 .18 0 .893 
3 .  lot 119C-7600 0  4 .62 0 .0  
4 .  ft  3  0 .52 0 .887 
5 .  lot 116C-7110 0  26.30 0 .0  
6 .  II  4  4 .66 0 .823 
7 .  II  8  3 .52 0 .866 
8 .  II  8^ 0 .37 0 .986 
9 .  II 11^ <0.05 >0.998 
10.  11 9^ <0.06 >0.998 
11.  II  7^ 0 .22 0 .991 
V^alues reported represent the concentration of aluminum contained in 
a 0.1 M solution of nucleotide. Standard errors of the values are 
+ 5% with a maximum accuracy of + 0.1 /ig. 
^The solution was equilibrated at room temperature for 16 h before 
extraction. 
^On the 8th extraction the pH was raised and after 30 sec. of mixing 
was again lowered. The solution was extracted 3 additional times 
following this step. (See the methods section for greater detail.) 
'^The nucleotide solution was extracted 2 times after the high pH step. 
Figure 1. Plot of -lo{;(vp vs. pH with 2.2 mM glucose and commercial 
(•) and aluminum-free (A) MgATP^ varied from 0.2 mM to 
1.0 mM. Th(; lines represent computer fits of the initial 
rate data as; described elsewhere (Solheim and Fromm, 1980). 
Experiments were carried out at 28°. Buffer concentrations 
were maintained at 10 mM in each experiment and were used 
within one pll unit of their pK. These curves are normalized 
to 0.005 unit of brain hexokinase used per assay. Other 
experimental details are available in the literature 
(Solheim and Fromm, 1980). 
-Log (V-i ) 
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ABSTRACT 
Two mechanisms have been suggested to account for the regulation of 
brain hexokinase by glucose 6-phosphate. One mechanism places glucose-
6-P at an allosteric site, remote from the active site, while the second 
describes glucose-5-P as a simple product inhibitor of the enzyme, binding 
at the 7-phosphate subsite within the ATP locus of the active site. To 
resolve this question, we have undertaken a study of the back reaction 
of hexokinase I. Our data indicate that glucose-6-P displays classical 
Michaelis-Menten kinetics with brain hexokinase. This finding is con­
sistent only with the high-affinity glucose-6-P site on the enzyme being 
the catalytic site. The dissociation constant estimated from the ini­
tial rate experiments is approximately 25 fiM, a value that agrees well 
with the inhibition constant for glucose-6-P in the forward direction. 
These findings are consistent with an earlier model (Ellison et al., 1975) 
which maintains that glucose-6-P inhibition of brain hexokinase is a 
manifestation of product inhibition. 
In a recent paper, Lazo ^  (1980) reported data obtained from 
binding studies with rat brain hexokinase at an elevated (250 fiM) level 
of glucose-6-P. These authors believe that their results indicate multi­
ple binding of glucose-ô-P to the enzyme and interpret the data in terms 
of a high-affinity allosteric site and a low-affinity catalytic site. 
Our results are at variance with this interpretation, and are consistent 
only with the high affinity site for glucose-6-P on brain hexokinase 
being the active site. 
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INTRODUCTION 
It is generally accepted today that hexokinase I, brain hexokinase 
is the pacemaker of glycolysis in brain tissue (Lowry and Passonneau, 
1964) and the erythrocyte (Rapoport, 1968). The observation by Tiedemann 
and Bom (1959), that (inorganic phosphate) increases the activity of 
glucose-6-P-inhibited brain hexokinase, provides an attractive model for 
coordinated glycolytic regulation in tissues that do not rely heavily on 
glycogen metabolism. However, an understanding of the molecular mechanism 
of brain hexokinase regulation requires knowledge of the nature of 
glucose-6-P binding to the enzyme. Most workers in this field believe 
that the regulatory ligand binds to an allosteric site in the enzyme. 
We, on the other hand, have maintained that the effect of glucose-6-P on 
hexokinase can best be explained by assuming that the sugar phosphate 
acts as a normal product inhibitor of the enzyme, binding tightly within 
also binds at an allosteric site, binding is very weak (Ellison et al., 
1975). 
To further elucidate the role of sugar phosphate in the hexokinase I 
reaction, we have undertaken initial-rate studies of the back reaction 
of the enzyme. Our results indicate that the reverse reaction of brain 
hexokinase displays classical Michaelis-Menten kinetics. Glucose-6-P 
binds to the active site of the enzyme with high affinity (K_^  = 25 ;xM) 
and shows substrate inhibition of the enzyme beginning at 60 piM. 
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Recently, Lazo ^  al. (1980) reported multiple binding of glucose-6-P 
to brain hexokinase. These findings led them to conclude that there are 
two binding sites for glucose-6-P per molecule of enzyme, one with a high 
affinity for ligand and the other with a much lower affinity. They 
interpret their results, as well as other data in the literature, to mean 
that the high-affinity binding of glucose-6-P occurs at an allosteric 
locus on hexokinase, whereas weak binding takes place at the catalytic 
site. 
In 1976, Sols (1976) reported that glucose-6-P is a classical sub­
strate inhibitor of the reverse reaction of an animal hexokinase. Until 
the recent report by Lazo ^  , we took this to be the final proof 
that glucose-6-P was in fact binding at the active site of hexokinase I. 
To resolve this question we undertook the current study and our findings 
strongly imply that the high-affinity binding site for glucose-6-P is 
the active site. 
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EXPERIMENTAL PROCEDURES 
Materials 
Glucose oxidase (210 units/iag) and horseradish peroxidase (250 units/ 
mg) were purchased from Boehringer Mannheim. Mutarotase was from Sigma, 
as was ADP, glucose-6-P, 4-aminoantipyrine, and PIPES buffer (piperazine-
N,N'-bis(2-ethanesulfonate)). Glucose dehydrogenase was kindly supplied 
by Dr. R. Ramaley of the Univ. Nebr. Med. School. Distilled-deionized 
water was used in the preparation of all reagents. All other chemicals 
were of the highest purity available commercially. 
Methods 
Bovine brain hexokinase was purified by the method of Redkar and 
Kenkare (1972) and had a specific activity of 62 units/mg. A unit of 
activity is defined as 1 ptmole of glucose 6-phosphate per minute at 28° 
standard assay contained 10 mM glucose, 5 mM ATP, 50 mM TRIS-Cl (pH 8), 
0.33 mM NADP, 7 mM MgCl^, and 1.7 units of glucose 6-phosphate dehydro­
genase in a total volume of 3 ml. 
The purified enzyme was stored as previously described (Redkar and 
Kenkare, 1972) and was desalted before each experiment on a Bio-Gel P2 
column, which had been equilibrated with 100 mM PIPES pH 6.0. The enzyme 
was found to be stable for at least 12 h after desalting. For initial-
rate studies, the enzyme was diluted into 1 mg/ml of bovine serum albumin 
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in 100 mM PIPES, pH 6.0. 
Aluminum, contaminating the commercial preparations of ADP and ATP, 
was removed by the procedure of Solheim and Fromm (1980) with 8-hydroxy-
quinoline in chloroform. The coupling enzymes were dialyzed against 5 
mM NaCl in 10 mM PIPES buffer, pH 6.0, overnight before used to remove 
ammonium sulfate which activated the reverse reaction. 
Reaction rates for the reverse reaction were determined in a Gary 
118c spectrophotometer by measuring the conversion of phenol and 4-amino-
antipyrine to quinoneimine in the glucose oxidase-peroxidase coupled 
assay (Gierow and Jergil, 1980). To verify that the rates measured were 
not limited by the coupling enzymes, various concentrations of hexokinase 
were added to assays containing constant amounts of mutarotase, glucose 
oxidase, and peroxidase. Hexokinase concentrations used in the initial-
rate experiments were from well within the linear portion of the velocity 
vs. enzyme profile. The typical assay contained 4 mM ADP, 10 mM MgClg, 
10 mM phenol, and 0.4 4-aminoantipyrins in 100 PIPES buffar pH 6.0. 
Glucose-6-P was varied from 3 pM to 450 ptM; 10 units of glucose oxidase, 
5 units of peroxidase, and 20 units of mutarotase were used in each assay. 
The reaction was initiated with brain hexokinase (0.06-0.01 units). To 
verify that changes in absorbance were due only to the reverse reaction 
catalyzed by hexokinase, two blanks were run. One contained the total 
assay mixture without hexokinase; the other contained hexokinase, but 
ADP and glucose-6-P were omitted. In each case, no change in absorbance 
was observed. 
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Initial-rate data were analyzed and fit to specific models by the 
weighted least-squares method, assuming equal variance of velocities» 
by a computer program written in the OMNITAB language (Siano £t , 
1975). The value of a was set equal to zero. Data where glucose-6-P 
inhibition was obvious were eliminated from the data set. 
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RESULTS 
In order to gain additional insight into the kinetic mechanism and 
mode of glucose-6-P binding in the brain hexokinase reaction, initial-
rate studies were undertaken for the reverse reaction. The data, plotted 
in the double reciprocal form, are shown in Figs. 1 and 2. The following 
conclusions can readily be drawn from these results: the kinetic mechan­
ism is sequential^ , the kinetics are Michaelian, and an evaluation of 
the Michaelis and dissociation constants can be made for the substrates. 
The kinetic mechanism of brain hexokinase is rapid-equilibrium random 
(Ning et al., 1969; Bachelard et al., 1971; Gerber et al., 1974). 
Since the reverse reaction is extremely slow, relative to the forward 
reaction, with conversion of the central complex the rate limiting step, 
binding of the substrates in the reverse reaction will be rapid-equilib­
rium as well (Fromm, 1975). 
The kinetic pararieters for the siibstrates are: 28.5 f 5.0 
14.8 + 5.1 pM, 1.66 + 0.53 mM, and 0.86 + 0.18 mM for ^j^gj^msQse-6-P' 
K T , K.,„, and K,„„, respectively. The two-fold discrepancy glucose-6-P lADP ADP 
between the K. , , „ value reported for this experiment and from iglucose-6-P 
experiments of the forward reaction (Copley and Fromm, 1967) is probably 
due to the fact that the latter experiments were carried out at pH 7.6. 
T^he nomenclature is that of Cleland (1963). 
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Recent studies of the reverse reaction from Sols' laboratory (1976) 
suggest that the brain hexokinase reaction is markedly inhibited at 
glucose-6-P levels exceeding approximately 0.1 mM. On the other hand, 
aside from the obvious excess substrate inhibition, there was no hint 
of sigmoidicity from his kinetic data. Because the experimental condi­
tions used in these studies were not available in the literature, we 
undertook the experiment illustrated in Fig. 3. These data confirm the 
findings of Sols (1976) and suggest that the back hexokinase reaction 
follows Michaelis-Menten kinetics. 
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DISCUSSION 
Lazo et al. (1980) have recently reported data from binding experi­
ments that they interpret to mean that two sites exist on hexokinase 
for glucose-6-P, one a high-affinity allosteric inhibitory site, and 
the other a low-affinity site. It will be useful in the development 
of this discussion to place this report in historical perspective. In 
1951, Weil-Malherbe and Bone (1951) published results indicating the 
noncompetitive nature of glucose-6-P inhibition of rat brain hexokinase. 
From their results, they concluded that glucose-6-P binds at a site 
other than the site or sites that bind either glucose or ATP, but that, 
when occupied, prevented catalysis. In their 1954 paper. Crane and 
Sols (1954) expanded upon this concept by requiring that the site of 
glucose-6-P inhibition be remote from the active site and that the sugar 
phosphate dissociate from and recombine with the enzyme to cause inhibi­
tion, This proposal has come to be regarded as the allosteric model 
of brain hexokinase regulation and is based in part on the observation 
that good substrates such as D-mannose, D-fructose, and 2-deoxy-D-glucose 
yield phosphorylated products, which either do not inhibit hexokinase 
or inhibit very poorly. Thus, it was suggested (Crane and Sols, 1954) 
that glucose-o-r and other sugar phosphates cannot bind to the same 
locus on the enzyme. Fromm and Zewe (1962) showed in 1962 that, although 
glucose-6-P inhibition relative to glucose was noncompetitive, the 
sugar phosphate affected the enzyme as a classical product inhibitor 
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with regard to ATP. These authors indicated that it was unnecessary 
to postulate a second site in the enzyme; rather, they suggested that 
the phosphate of glucose-6-P interacts primarily with the 7-phosphate 
subsite of the ATP pocket on brain hexokinase. Other investigators 
have obtained similar product inhibition data with hexokinase I (Rapo-
port, 1968; Copely and Fromm, 1967; Grossbard and Schimke, 1966; Uyeda 
and Racker, 1965). Replots of double-reciprocal data shown in a report 
by Ellison et (1975) and which we have drawn from the data of Gross­
bard and Schimke (1966), indicate that glucose-6-P is a linear competi­
tive (relative to ATP) or linear noncompetitive (relative to glucose) 
inhibitor of hexokinase I, even at high concentrations of the sugar 
phosphate (1000 (xM and 450 piM, respectively). These data indicate that 
only one inhibitor molecule binds per enzyme monomer. Additional work 
by Purich and Fromm (1971 and 1972a) has shown that glucose-6-P is a 
potent inhibitor of brain hexokinase even in the presence of high 
concentrations of nucleotides, and finally, recent work by Casazza and 
Fromm (1976) has shown that, contrary to the suggestion of Crane and 
Sols (1954), mannose-6-P inhibits brain hexokinase in an identical fash­
ion with that of glucose-6-P, but with a lower affinity for the enzyme. 
This result has been confirmed in the recent report by Lazo et (1980) 
in which their binding studies indicate that manncss—6-P, as well as 
the sugar phosphates of other alternative substrates, was able to compete 
with glucose-6-P for the high-affinity binding site on brain hexokinase. 
One of the seeming anomalies in the proposal of Fromm and his co-
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workers comes from their suggestion originally alluded to from kinetic 
studies (Rapoport, 1968; Copley and Fromm, 1967; Weil-Malherbe and Bone, 
1951; Crane and Sols, 1954; Fromm and Zewe, 1962; Grossbard and Schimke, 
1966; Uyeda and Racker, 1965) and subsequently confirmed by binding 
experiments (Ellison et al., 1975; Lazo ^  , 1980; Ellison et al, 
1974), that an abortive complex of enzyme-glucose-glucose-6-P forms 
at the enzyme's active site. The model of Crane and Sols (1954), and 
now espoused by Wilson (Lazo et , 1980), would place glucose at the 
active site and glucose-6-P at an allosteric site. Quite clearly the 
sugar phosphate must bind to the active site and Lazo et (1980) in 
their recent study have provided for two glucose-6-P binding sites. 
Our view (Ellison al., 1975) is that in the forward reaction, after 
glucose-6-P is formed, the phosphate moiety is anchored to the Y-phos­
phate subsite of the ATP locus on the enzyme. The glucose portion of 
the glucose-6-P next binds to a new position on hexokinase where the 
binding determinants differ somewhat from the binding determinants at 
the glucose subsite (Ellison ^  , 1975). This explains the different 
specificities of the two subsites and permits formation of the abortive 
ternary complex. The rationale for the different specificities of the 
sugars and sugar phosphates are presented elsewhere (Casazza and Fromm, 
1976). Abortive complex formation leads to tighter binding of glucose-
6-P (Ellison ^  £l•, 1975; Lazo et ^ ., 1980) as a consequence of the 
law of mass action. 
In addition to the binding experiment at low glucose-6-P concentra-
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tion, referred to above, Lazo ^  al• (1980) also conducted an experiment 
at high glucose-6-P concentration, which led the authors to conclude 
that brain hexokinase had two binding sites for glucose-6-P, a high-
affinity allosteric site and the low-affinity catalytic site. However, 
there are several problems associated with this report which led us to 
question the reliability of the data of Lazo e_t (1980). These are 
as follows: 1. The authors admit that because of technical difficulties 
with their assay, Scatchard plots could not be constructed, and they 
rely upon binding experiments performed at one concentration (250 /iM) 
of glucose-6-P to support their conclusions. 2. Although their data 
(Table I) indicate that 1 mM 2-deoxyglucose-6-P is able to reduce by 
half the binding of glucose-6-P to the high-affinity site at 5.4 fzM 
glucose-6-P, the authors state that "2-deoxyglucose-6-P is a poor 
ligand for the inhibitory site and thus would be ill-suited to compete 
with glucose-6-P at this site." Furthermore, because 2-deoxyglucose-
6-P is a substrate for hexokinase (Sols, 1976), it must bind to both 
sites. This analog, at a concentration of 10 mM, however, can only 
displace glucose-6-P from 1 site (Table II (Lazo et al., 1980)), 
presumably the allosteric site (see Table I (Lazo e^  , 1980)). Yet, 
Lazo et (1980) go on to state that "weak binding of 2-deoxyglucose-
6-P at the inhibitory site is also consistent with the failure of 2-deox}'-
glucose-6-P to inhibit brain hexokinase when the reverse reaction is 
studied". The inhibition referred to is relative to glucose-6-P inhibi­
tion (Fig.3 and (Sols, 1976)) and is low-affinity excess substrate 
inhibition. 
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In this context, the data of Table I (Lazo et al., 1980) show that 
1,5-anhydroglucitoi-ô-P is effective in removing glucose-6-P from the 
allosteric site, as is 2-deoxyglucose-6-P. Lazo et al. (1980) state 
"in combination, 2-deoxyglucose-6-P and l,5-anhydroglucitol-6-P virtually 
abolish binding of glucose-6-P". It is not at all clear how two ligands 
that compete for the allosteric site (Table I (Lazo et al., 1980)) can 
effectively remove glucose-6-P from both sites. 3. In order for the 
results of Fig. 3 or of Sols' data (Sols, 1976) to be consistent with 
the Lazo-Sols-Wilson model (Lazo ^  , 1980), a third type of binding 
site, weaker in affinity than either the postulated alio or active sites, 
must be proposed, i.e., the inhibitory effect at this site is manifested 
only at very high levels of glucose-6-P. 4. Most troubling is the 
result obtained when the binding of glucose-6-P to hexokinase I is 
measured in the presence of glucose. At the concentration of glucose 
used in the experiment (20 mM), the binding site for glucose is saturated, 
i.e.. the for glucose is approximately 40 This precludes bind­
ing of glucose-6-P at the glucose binding site of the enzyme, and the 
ratio of binding of glucose-6-P per molecule of hexokinase cannot be 
greater than 1. The value determined by Lazo et al. (1980) is 1.34 + 
0.26 in 6 determinations. Because this value cannot be greater than 
unity, one must conclude thar the excess in the value is due to the 
technical difficulties alluded to in the manuscript. If one now com­
pares this value to that determined in the absence of additions (1.55 
+ 0.39 in 17 determinations) with a simple t test, one finds that these 
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values are not significantly different at the 20% level. Although this 
limitation is acknowledged by Lazo et ^.(1980), they suggest that the 
glucose analog N-acetylglucosamine (10 inM) "produced a substantial 
decrease in glucose-6-P binding". Yet we found that there is no sta­
tistical difference between the values for 10 mM glucose and 10 mM 
N-acetylglucosamine. These results lead one to question whether any 
of the binding data at high levels of glucose-6-P provide meaningful 
results. In an attempt to explain why glucose is an ineffective inhib­
itor of glucose-6-P binding to the active site, Lazo et al. (1980) 
evoke the concept of synergistic interactions between the two hexose 
binding sites. They suggest that although glucose enhances binding 
of glucose-6-P to the regulatory site, it may be that binding of the 
sugar phosphate to the catalytic site may have an adverse effect on 
binding of glucose-6-P to the regulatory site. 5. Finally, binding 
data do not provide any information about the progress of an enzymatic 
reaction and thus cannot tell what effect a ligand has cn the course of 
the catalytic reaction. 
Because of the problems involved in interpreting the work of 
Lazo et (1980), and generally because of the inability of binding 
data to provide information dealing with enzyme catalysis, we have 
undertaken the study of the back reaction of bovine brain hexokinase to 
determine the characteristics of the glucose-6-P binding site (Figs. 1 
and 2). Fig. 3 illustrates the velocity dependence of the reverse reac­
tion of glucose-6-P at a fixed concentration of ADP. These data describe 
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classical substrate inhibition and show beyond doubt that high-affinity 
binding by the sugar-phosphate occurs at the active site of hexokinase 
I. The apparent K^ , estimated from this profile, is approximately 
20 fiM. This value is in good agreement with the (~12 pM) for 
glucose-6-P inhibition of hexokinase I in the forward direction 
(Rapoport, 1968) and with the values determined for the reverse reaction 
in Figs. 1 and 2. As a confirmation of this profile, the experiment 
described by Fig. 3 was repeated with glucose dehydrogenase as the 
coupling enzyme. The profile was qualitatively identical with Fig. 3 
and yields an apparent of 20 to 30 fxM. It is of some interest that 
these results are qualitatively identical with findings published by 
Sols in 1976 (Sols, 1976). Taken at face value these results seem to 
exclude glucose-6-P binding at a high-affinity allosteric site. It is 
important to note that the dissociation constant determined for glucose-
6-P is similar whether it is a product inhibitor (forward reaction) or 
a substrate (reverse reaction). 
The Lazo-Sols-Wilson model (Lazo et al., 1980) of hexokinase 
regulation by glucose-6-P in fact requires 3 sugar phosphate binding 
sites. At low levels of ligand, in the presence of ADP, binding would 
occur at the high-affinity allosteric site and no reaction would occur. 
As the level of glucose-o-P is increased, giucose-6-P would bind to the 
catalytic site and leave the allosteric site (Lazo et al., 1980). In 
order to explain the substrate inhibition at still higher levels of 
glucose-6-P (Fig. 3 and (Sols, 1976)), one would have to postulate 
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either a lower-affinity inhibitory allosteric site for ligand or a 
mechanism for rebinding of glucose-6-P at the high-affinity allosteric 
site. In addition to all of this, the model requires synergistic inter­
actions between the ligands at the allosteric and catalytic sites 
(Lazo et al., 1980). This is a highly complex and unprecedented pro­
posal when compared to our model which can account for the effects of 
glucose-6-P using classical assumptions of product and substrate inhi­
bition (Ellison e^  , 1975). Although it is difficult to prove that 
the latter model is correct, it is clear, at least in our opinion, that 
the Lazo-Sols-Wilson model (Lazo e^  a^., 1980) is incorrect. We arrive 
at this conclusion based not only on the inconsistencies alluded to 
regarding the findings of Lazo et al. (1980), but also based on the 
type of kinetic response one could predict for brain hexokinase when 
the reverse reaction is studied. 
The mechanism for substrate inhibition (for simplicity represented 
as a one substrate system) is shown in Scheme I 
A P 
A 
Ë ËÂ fÂ ËÂ Ë 
EA^  
and has a rate equation of the type described by Eq. 1 
V 1 
v 
(1) 
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where K is the Michaelis constant for A, and K. is the dissociation 
a 1 
constant for the EA^ complex. The results of Fig.3 and the data of 
Sols (1976) are in harmony with Eq. 1 and, thus, with the mechanism in 
Scheme I. It is of interest to note that multiple binding of glucose-
6-P is not seen in the forward reaction when studies of glucose-6-P 
inhibition of brain hexokinase are undertaken even at elevated levels 
of the inhibitor (Ellison et al., 1975; Grossbard and Schimke, 1966). 
This is not an unusual occurrence, inasmuch as enzymes often show sub­
strate inhibition when studied from the nonphysiological direction. 
Because hexokinase I is believed to operate with a rapid equilibrium 
random mechanism (Ning et al., 1969; Bachelard et al., 1971; Gerber 
et al., 1974), this inhibition is most likely due to the addition of 
glucose-6-P to the E*ADP*G-6-P ternary complex (Fromm, 1975; Cleland, 
1979). Ironically, the incidence of the substrate inhibition lends 
support to Lazo et 's (1980) contention that there are two binding 
strongly that the evidence supports binding with high affinity at the 
active site of the enzyme, with only weak binding at a second site. 
The mechanism proposed by Lazo ^  (1980) is actually a mani­
festation of substrate activation by glucose-6-P when looking at the 
back reaction of hexokinase. If we assume for simplicity that we are 
dealing with a one-substrate system, the Lazo-Sols-Wilson model (Lazo 
et al., 1980) can be described by either of two mechanisms shown in 
Schemes II and III. 
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EA EAg EA 
Scheme II 
k 1+ 2 '"Si 4 5 k, kr 
P 
A 
^6 7^ 
EA^ EA' 
Scheme III 
The mechanism in Scheme II is an example of classical substrate 
activation and leads to a rate equation of the type shown in Eq. 2. 
V, 
V = 
^i i^a 1 + — + • K. 
(2)  
where K. is the dissociation constant for EA and K. is the dissociation la 1 
constant for the EA2 complex. The rate expression for the mechanism 
for Scheme III, assuming the steady-state assumption, is of the form 
V, 
1. +5: 
A 
K. 
(3) 
1^ = k.k. + k,k. + k.k 
3 5 "4 6 3 7 
K 
' 1 k^ kc + k.kf + k,k 
"3 5 % 6 3 7 
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i^i - + k,k,|—- • 
k,k.(k, + kr) 
K ,= 
a k^Ckgkg + k^ kg + k^ky) 
and arises from the model of Lazo et al. (1980). In this model, glucose-
6-P binds first to the high-affinity allosteric site and then to the 
low-affinity active site. Furthermore, when binding occurs at the 
catalytic site, the sugar phosphate dissociates from the allosteric site. 
This model predicts that a plot of velocity vs. A will be sigmoidal at 
low substrate concentrations, reach a maximum, and approach zero as a 
limit. The initial, sigmoidal portion of this type of profile is 
illustrated in Fig. 4. It is of interest to note that in the model 
described by Scheme III, it is not necessary to suggest an additional 
site for glucose-6-P. The data of Figs. 1-3 and results from Sols' 
laboratory (Sols, 1976) argue against sigmoidicity at low substrate 
levels of glucose-6-P. One could suggest, of course, that the sigmoid­
icity exists, but is too subtle to be discerned. The suggestion must 
be viewed, however, in context of what is known regarding the mechanism 
of inhibition of brain hexokinase by glucose-6-P and the fact that the 
Kïglucose-6-P is 20 pM. 
The data of Figs, 1 and 2 permit calculation of the kinetic param­
eters for the reverse hexokinase reaction, and provide us with a fuller 
understanding of how brain hexokinase is coordinately regulated by its 
products. We proposed some time ago (Purich and Fromm, 1972b) that the 
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kinetic mechanism may play a fundamental role in enzyme regulation. 
Purich and Fromm (1971, 1972a) reported that hexokinase is inhibited 
about 65% by intercellular levels of ADP and other nucleotides and 
approximately 75% by intracellular levels of glucose-6-P. On the other 
hand, these effectors exhibit synergism when present together and pro­
duce approximately 95% inhibition of the brain hexokinase reaction. 
These data were obtained in the absence of phosphate which modulates the 
flux through the hexokinase reaction by deinhibiting the glucose-6-P 
inhibited enzyme (Ellison et , 1975). To explain these findings, 
we used the rate equation for the rapid-equilibrium random Bi Bi mechan­
ism and the kinetic parameters obtained from this and another report 
(Ellison et al., 1974). 
V = 
(Glc)(ATP) - (Glc-6-P)(ADP) V 1 
\TP (Glc) + K,,j(ATP)(G1C) + i!i{V 
eq L  ^
+ K (Glc- 6-P) + (ADP)(Glc-6-P) (4) 
-3 -3 
V = 6.4 X 10 with both products present, and 21.1 x 10 and 
13.1 X 10 ^  with only ADP or glucose-6-P present alone, respectively. 
These calculations indicate that both products aid to inhibit the hexo­
kinase reaction so as to dampen and thus control the potentially rapid 
flux through the hexokinase reaction when the level of phosphate increases 
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in the brain cell in order to increase glycolysis (Purich and Fromm, 
1971; Purich and Fromm, 1972a). 
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Figure 1. Plot of the reciprocal of initial velocity (v) versus 
the reciprocal of the molar concentration of glucose 6-
phosphate at 1.0 mM (#), 0.50 mM (A), 0.33 mM (•), 
0.25 mM (•), and 0.20 mM (+) MgADP . Glucose-6-P was 
varied from 12.5 /xM to 66.7 ^ M. Other experimental 
details are described under "Experimental Procedures". 
1/V is expreiSijed in (molar/min) ^  and l/Glc-6-P is (molar) \ 
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Figure 2. Plot of the reciprocal of Initial velocity (V) versus 
the reciprocal of the molar concentration of MgADP at 
40 (•), 25.0 nM (A), 16.7 fiM (•) , and 12.5 (+) 
glucose-6-P. MgADP was varied from 0.20 mM to 1.0 mM. 
Other experimental details are described under "Experi­
mental Procedures". 1/MgATP is expressed in (molar) ^  
and 1/V is in (molar/min) ^ . 
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Figure 3. Plot of Initial velocity versus glucose-6-P concentration 
in the presence of 4 mM ADP. Assays were performed as 
outlined in the "Experimental Procedures". Each assay 
contained 0.06 I.U. of bovine brain hexokinase, as assayed 
in the forward direction. Velocity is expressed in molar/min. 
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Figure 4. Theoretical plot of initial velocity versus glucose-6-P 
concentration. 
(a) generated from Eq. 1 where = 300 pM, = 25 /xM, 
and == 1. 
(b) generated from Eq. 3 where = 300 = 25 fxM, 
K I = 400 and V, = 1. K,, and K , in Eq. 3 are 
a r- > 1 ii a 
analogous to and respectively, in Eq. 2. 
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SUMMARY AND DISCUSSION 
Investigations into the kinetic mechanism and regulation of hexo­
kinase I have been progressing for the last 25 years. During this period, 
a comprehensive model for the action of the brain isozyme has been devel­
oped. It is now established that the kinetic mechanism of brain hexokinase 
is rapid equilibrium random (Ning ^  , 1969; Bachelard et , 1971; 
Gerber ejt al., 1974) and with the exception of a disagreement on the mode 
of action of glucose-6-P inhibition, the regulation of hexokinase I by 
glucose-6-P and is accepted and recognized as the primary control 
point of energy metabolism in nonglycogen using tissues. In the present 
studies, we have attempted to gain information about the groups involved 
in binding and catalysis of substrates in the hexokinase reaction and 
to resolve the question of the site of action of glucose-6-P on the 
enzyme by a study of the reverse reaction kinetics. 
T"Ko tyî5"r**î 5 t-Tryf -n î3 T-tarnoi-OT-c; t.t*i *-V» "nW T.Tfl ^ o-vaTT<-î rt oH f m-r "HnTT"!T>o 
brain hexokinase using glucose and MgATP as substrates. The Dixon plots 
generated from the data yielded profiles with limiting slopes approaching 
-1 on the acid side of the pH scale. No variation in activity was 
observed at basic pH values. From a comparison of 3 types of data, the 
pK's of ionizing groups affecting enzyme activity, changes in these pK's 
with temperature, and the effect of organic solvent on the pK values, 
tenative assignments of residues have been made for the detected ioniza­
tions. Breakdown of the ternary complex (E-Glc*MgATP) to product appears 
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to be facilitated by histidine residue as does binding of MgATP to the 
E'Glc complex. A neutral acid group, possibly aspartate or glutamate, 
appears to be involved in the binding of glucose to the E-MgATP complex. 
Whether these residues are directly interacting with the substrates in 
the reaction or are important in maintaining the active configuration of 
the enzyme, cannot be determined by this technique. 
During the course of these investigations, an anomalous inhibition 
of the enzyme was observed around neutral pH. This inhibition was traced 
to an aluminum contamination of commercial preparations of ATP. The 
observed inhibition could be reversed by the addition of citrate to the 
reaction mixture but citrate had no effect on the enzyme other than 
relief of the aluminum inhibition. Kinetic data indicated that aluminum 
inhibited the enzyme in a competitive manner with respect to ATP and is 
probably acting in the form of an AlATP complex. 
In order to determine the effect that the aluminum inhibition had 
on estimation of the pK's; we developed a method for removing aluminum 
from ATP. The method, which removes greater than 99% of the aluminum 
from the nucleotide, involves repeated extraction of the nucleotide 
solution with 8-hydroxyquinoline in chloroform at basic pH. Analysis of 
several lots of ATP indicated that the quantity of contamination varied 
greatly and that the extraction procedure removed virtually all of the 
contaminant. Regeneration of the pH profiles using the purified ATP 
preparations yielded Dixon profiles with no significant variation from 
the original data. 
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In an attempt to resolve the question of the site of action of 
glucose-6-? on the enzyme, a study of the reverse reaction of brain 
hexokinase was undertaken. The initial rate studies using glucose-6-P 
and ADP as substrate indicated that hexokinase I displayed normal 
Michaelian kinetics. Glucose-6-P bound to the enzyme with high affinity 
(K^ ~^25 fiM) and displayed inhibition only at elevated concentrations of 
sugar phosphate. These data are only consistent with the high-affinity 
site for glucose-6-P on brain hexokinase being the active site. 
To further elucidate both the chemical mechanism and the role of 
glucose-6-P in the regulation of hexokinase I additional experiments are 
being undertaken. These studies take two forms: i) kinetic studies on 
the reverse hexokinase reaction to determine the effect of inorganic 
orthophosphate on the reaction, and ii) chemical inactivation of the 
enzyme using active site directed protein modification reagents. 
Since phosphate relieves inhibition by glucose-6-P when the enzyme 
is assayed in the forward direction, the effect of phosphate on the 
reverse reaction should provide addition evidence on the site of action 
of glucose-6-P. These data, plus additional experiments determining the 
effects of products, ATP, and hexose, on the reverse reaction, will 
allow the construction of a more complete description of the hexokinase 
mechanism. 
The use of analogs for ATP such as 5'-fluorosulfonylbenzoyladenosine 
(Colman et al., 1977) and 8[m-(m-fluorosulfonylbenzamido)benzylthio] 
adenine (Baker and Kozma, 1968) will allow direct probing of the active 
Ill 
site of the enzyme. These reagents, unlike that used by Subbarao and 
Kenkare (1977b) place the reactive portion of the molecule in the area of 
the phosphates. Modification of the enzyme in this location should 
provide information on both catalysis and regulation of the enzyme. A 
survey of protection from inactivation provided by substrates and 
products may allow one to determine common loci of interaction on the 
enzyme, specifically in this instance whether or not glucose-6-P and 
ATP are interacting at a common site. Furthermore, isolation of peptides 
and residues modified by the reagent can allow identification of resi­
dues in and about the enzyme's active site. 
Because of its unique position as a control point of glycolysis, 
hexokinase I has been extensively studied to delineate its kinetic and 
regulatory mechanism. The present studies address two of the remaining 
questions about mode of action of this important enzyme. Evidence 
for glucose-6-P acting within the ATP binding site has been presented 
the hexokinase reaction. In addition, data derived from the effect of 
changing pH upon the kinetic parameters indicate two types of residues 
important in hexokinase activity. These residues are histidine, acting 
in the binding of ATP and in the breakdown of the ternary complex, and 
an acid residue acting in the binding of glucose to the E"ATP complex. 
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